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Abstract
BACKGROUND: The virtual delivery of lifestyle medicine programs (e.g., via webconferencing platforms) can increase program accessibility for adults living with type 2
diabetes (T2D). PURPOSE: To assess the feasibility of virtually delivering a multicomponent group-based lifestyle medicine program that uses wearable technologies and
exercise prescriptions in an adult population with T2D. METHODS: This was a six-week,
single-cohort feasibility study. The virtual lifestyle medicine program included live-video
delivery of group education classes, one-on-one exercise counselling phone calls, flash
glucose monitors, wearable activity monitors, and exercise prescriptions. Several feasibility
outcomes were assessed including recruitment and retention rates, acceptability (e.g., exit
survey), and adherence (e.g., group education class attendance). Data are reported
descriptively. RESULTS: Ten participants with T2D were recruited (60% female, 50 ± 15
(SD) years, mean A1c 6.7 ± 0.5 %). Recruitment and retention rates were 29% and 80%,
respectively. Most participants (89%) were ‘satisfied’/‘very satisfied’ with the program.
There were 3.2 ± 2.6 technology ‘issues’ reported per person, mostly related to study data
transfer. Participants attended 83% and 93% of group education classes and one-on-one
exercise counselling phone calls, respectively. CONCLUSION: The virtual delivery of a
multi-component group-based lifestyle medicine program for adults living with T2D is
feasible, however, several study protocol and interventions refinements are recommended
before conducting a larger trial.
Keywords
Type 2 Diabetes, Virtual Care, Self-Management, Wearables, Activity Monitor, Continuous
Glucose Monitor, Exercise Prescription, Physical Activity, Lifestyle Medicine, Nutrition,
Group Education
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Summary for Lay Audience

To address common barriers to self-management education in populations with type 2
diabetes, effective delivery of virtual group lifestyle medicine programs is needed. This was
a six-week, single group study that assessed the feasibility of delivering a virtual group
lifestyle medicine program that used wearable glucose monitors and activity monitors (i.e.,
FitBit Inspire 2™), and provided personalized exercise prescriptions for patients with type 2
diabetes. This study was conducted through a specialized primary care clinic in London,
Ontario. Adults (≥18 years) with type 2 diabetes who owned a smartphone, had Internet
access, and were medically cleared to exercise, were included. During a two-week baseline
and six-week intervention, participants wore wearable glucose monitors and FitBit Inspire
2™’s. Virtual group education classes (via a videoconferencing platform) and one-on-one
exercise counselling phone calls (with an exercise specialist) were delivered bi-weekly, on
alternating weeks. Virtual group education classes covered content such as low carbohydrate
nutrition topics, how to interpret and use glucose data to make nutrition and exercise
decisions, why and how to exercise, and learning coping/problem solving skills. Data (n=10
participants) reported an 80% retention rate at follow-up, 3.2 ± 2.6 mean technology issues
per person, high participant satisfaction (89%), and intervention adherence rates of 83% and
93% for group and phone call check-in attendance, respectively. Several opportunities for
refinement were found to help inform a pilot study. This work may lead to better, more
accessible virtual group education for patients with type 2 diabetes and reduce healthcare
worker burden.
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Chapter 1

1

Introduction

1.1 Background
In 2020, an estimated 3.77 million (10%) Canadians were living with diagnosed type 1 or
type 2 diabetes mellitus (T2D), where T2D made up about 90-95% of all cases (Diabetes
Canada, 2021a). The prevalence is expected to increase approximately 30% by 2030
(Diabetes Canada, 2021a). In general, adults living with T2D have higher rates of
morbidity (e.g., cardiovascular disease hospitalizations) and mortality (e.g., all-cause
mortality; Hux et al., 2003; LeBlanc et al., 2019). Better T2D self-management and
glycemic control can slow disease progression as well as decrease the risk of
complications (e.g., neuropathies; Imran et al., 2018). Those living with T2D experience
many challenges that are related to self-management, including: (a) demanding treatment
regimens, (b) increased family burden, (c) higher levels of mental and emotional strain,
(d) financial burden, and (e) decreased quality of life (Gonzalez et al., 2016; Harding et
al., 2019; Houlden, 2018; Nicolucci et al., 2013). More accessible T2D self-management
solutions are needed to help address some of these challenges and decrease disease
burden (Banbury et al., 2018; Horigan et al., 2017; Powers et al., 2015).

1.2 Self-Management
Diabetes self-management is often described as a ‘full-time’ job (Gonzalez et al., 2016),
with healthcare-related decision making, symptom monitoring (e.g., hypoglycemia), and
treatment regimens (e.g., insulin injection) required multiple times a day, every single
day (Chodosh et al., 2005; Gonzalez et al., 2016; Sherifali et al., 2018). Aspects of T2D
treatment regimens generally belong to four main ‘pillars’ of diabetes self-management,
including: (a) regular glycemic monitoring (Berard et al., 2018), (b) medication
adherence (Khunti et al., 2017), (c) proper nutrition (Sievenpiper et al., 2018), and (d)
sufficient physical activity/exercise (Colberg et al., 2010; Colberg et al., 2016; Marçal et
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al., 2020; Sigal et al., 2018; Warburton & Bredin, 2017; Zhao et al., 2020). In particular,
the evidence-base is growing to support exercise as a daily cornerstone of treatment
(Sigal et al., 2018). Unfortunately, under the current circumstances, the COVID-19
pandemic (including stay-at-home orders, a generalized fear of infection, etc.) has led to
decreased physical activity levels and increased sedentary behaviours in the general
population globally (Marçal et al., 2020) and possibly in those with T2D as well. Another
consequence of the COVID-19 pandemic has been rising levels of anxiety and depression
amongst those living with T2D (Marçal et al., 2020), which has been previously shown to
limit the quality of chronic disease self-management (Grenard et al., 2011). Before the
COVID-19 pandemic, this clinical population often demonstrated sub-optimal treatment
adherence and glycemic control (Coons et al., 2017; Polonsky & Henry, 2016). The
added pressures of the COVID-19 pandemic are expected to exacerbate the low treatment
adherence issue, leading to poorer glycemic control and increased rates of T2D
complications (Marçal et al., 2020). Now, almost more than ever before, adults living
with T2D need accessible self-management supports (Aberer et al., 2021; Sauchelli et al.,
2021).

1.3 Self-Management ‘Boosters’
The T2D self-management literature suggests that diabetes self-management education
(DSME), theory-based interventions, and technologies (e.g., wearable activity monitors,
smartphone applications [apps], etc.) may promote health behaviour change and improve
glycemic outcomes (Gonzalez et al., 2016; Kirk et al., 2019; Kooiman et al., 2018; Liao
et al., 2020; Lystrup et al., 2020; Patel et al., 2015; Shan et al., 2019; Sherifali et al.,
2018; Shigaki et al., 2010; Sigal et al., 2018; van Ommen et al., 2017; Williams et al.,
2004). DSME is a collaborative and interactive process between patients and providers
that helps patients learn the knowledge and skills needed to better manage their T2D
(Chodosh et al., 2005; Sherifali et al., 2018). When grounded in behaviour change theory,
DSME has shown to be more efficacious (Ntoumanis et al., 2020; Sheeran et al., 2020).
Self-determination theory (SDT), a global theory of human motivation (Ryan & Deci,
2000b), has previously informed effective DSME interventions (Karlsen et al., 2018; Liu
et al., 2018; Williams et al., 2009) and been applied in exercise-based interventions
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(Koponen et al., 2018; Sigal et al., 2018; Silva et al., 2010). SDT offers a framework for
developing health behaviour interventions by nurturing intrinsic motivation through the
satisfaction of three basic psychological needs: autonomy, relatedness, and competence
(Ryan & Deci, 2000b, 2017). Evidence suggests that behaviour change techniques
(BCTs) can be used to support these psychosocial needs and help patients internalize the
motivation to engage in self-management practices (Michie et al., 2013; Ntoumanis et al.,
2020). BCTs are the “active ingredient” components in an intervention that have
previously shown observable, reproducible results that are designed to alter causal
processes that regulate behaviour (Michie et al., 2013). For example, the incorporation of
specific BCTs (i.e., enhanced self-monitoring or goal setting) have been linked to
increased feelings of self-efficacy in adult populations with T2D (Fredrix et al., 2018;
McSharry et al., 2020; McSharry et al., 2016).
Virtually delivering group education classes has the potential to create feelings of social
relatedness as well as offer an inclusive environment that one-on-one sessions cannot
(Cliffe et al., 2021; Jiwani et al., 2021; Ryan & Deci, 2017). As well, it can increase
opportunities for peer learning and acknowledgement of feelings from and by, clinicians
and peers, which can assist in the development of autonomy and relatedness (Ryan &
Deci, 2017; Williams et al., 2004). Wearable technologies (particularly when used in a
DSME environment) can be beneficial for building intrinsic motivation as well. Wearable
technologies such as flash glucose monitors (FGMs; i.e. FreeStyle® Libre, Abbott
Laboratories Ltd., Illinois, United States) and wearable activity monitors (e.g., FitBit
Inspire 2™, FitBit Inc., San Francisco, California) can support increased feelings of selfefficacy for diabetes self-management behaviours by providing positive performance
feedback (e.g., biofeedback) and optimal challenges (e.g., scalable physical activity
goals; Ryan & Deci, 2017). Wearable technologies can also support autonomy by
providing patients with increased opportunities for treatment-related choices (e.g.,
selecting their own physical activity goals; Ryan & Deci, 2017) and social-connectedness
(such as sharing experiences using tracked data (e.g., ‘I can’t believe what happened to
my blood glucose after I went for a walk.’; Kooiman et al., 2018; Lystrup et al., 2020;
Michaud et al., 2021; Rollo et al., 2016; Shan et al., 2019; Sherifali et al., 2018; Sigal et
al., 2018; van Ommen et al., 2017). T2D self-management, therefore, may be improved
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with DSME that is grounded in health behaviour change theory and that leverages virtual
group education classes and wearable technologies (Gonzalez et al., 2016; Whelan et al.,
2019).

1.4

New Virtual Possibilities

As a result of the COVID-19 pandemic, methods of virtual care are being used at
unprecedented rates (e.g., virtual patient/provider group videoconferencing platforms
such as Zoom or WebEx®, etc.; Zhang et al., 2021). Virtual care is an all-encompassing
term and is defined as, “any interaction between patients and/or members of their circle
of care, occurring remotely, using any forms of communication or information
technologies, with the aim of facilitating or maximizing the quality and effectiveness of
patient care.” (Jamieson et al., 2015, p. 5). Methods of delivering virtual care can address
common self-management barriers (e.g., time intensive treatment tasks such as taking
public transit to medical appointments) and increase access to timely T2D support and
education (Gonzalez et al., 2016; Horigan et al., 2017; Robinson et al., 2018; Zgibor &
Songer, 2001). Previous evidence has shown that the virtual delivery of DSME (with or
without the use of wearable technology) may be as effective as face-to-face delivery and
can result in positive health behaviour changes (Komkova et al., 2019; Li et al., 2020;
Ward et al., 2018; Wolever et al., 2010). There has been a rapid transition to virtual care
across many jurisdictions around the world in response to the COVID-19 pandemic
(Aberer et al., 2021; Zhang et al., 2021). This response presents an opportunity to
examine and improve the virtual delivery of DSME programs (Aberer et al., 2021). What
once was a less common, alternative medium is (for now and for many) the standard of
care (Aberer et al., 2021; Iyengar et al., 2016). Necessity certainly does breed innovation.

1.5 Virtual Lifestyle Medicine
Little is known about the feasibility of virtually delivering multi-component group-based
lifestyle-focused DSME (or “lifestyle medicine programs”). To date, virtual lifestyle
medicine programs have primarily been delivered in human resource-intensive, one-onone formats (Kato et al., 2020; Majithia et al., 2020; Michaud et al., 2021; Wayne et al.,
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2015; Wolever et al., 2010; Zheng et al., 2020), potentially limiting program scalability
and sustainability (Marzolini et al., 2021). As well, while many virtual lifestyle medicine
programs in T2D settings include an exercise component, most appear to lack
individualized exercise prescriptions which may limit behaviour change potential (Kato et
al., 2020; Li et al., 2020; Liao et al., 2020; Majithia et al., 2020). A recent focus group
study by Jiwani and colleagues (2021) examined the acceptability of a multi-component
virtual lifestyle medicine program that included group education and wearable monitors
(n=18; older adults living with overweight/obesity and T2D aged 72 ± 5.4 years).
However, despite promising results, a broader range of feasibility (e.g., recruitment rate,
intervention adherence, etc.) and health behaviour/outcome metrics are needed to refine
these virtual interventions, and ultimately establish their efficacy. Aligning with the
ORBIT Model for Developing Behavioral Treatments for Chronic Diseases (Czajkowski
et al., 2015), our clinically significant question (and marker of change) defined by
ORBIT Phase 1a: “What is the effect of a multi-component (e.g., wearable technology,
exercise prescriptions) virtual lifestyle medicine program on A1c in adults with T2D?”.
As well, a behavioural risk factor (exercise), potential candidates (adults with T2D), and
intervention components and their targets (i.e., step count prescriptions and change in
daily step count) were delineated in advance for the purpose of this. In order to prepare
for a proper Phase III efficacy trial, the primary objective of this study, therefore, was to
assess the feasibility of delivering a multi-component virtual lifestyle medicine program
for adults with T2D. This preparatory research (ORBIT Phase Ib) will help set the stage
for a pilot randomized controlled trial (RCT) that tests the impact of virtual vs. in-person
delivery of a multi-component lifestyle medicine program.
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Chapter 2

2

Literature Review

2.1 Type 2 Diabetes Mellitus: Prevalence and Burden
“Diabetes mellitus is a heterogeneous metabolic disorder characterized by the presence of
hyperglycemia due to impairment of insulin secretion, defective insulin action or both”
(Punthakee et al., 2018, p. S10). More specifically, T2D is a chronic disease,
characterized by the inability to produce a sufficient amount of insulin, or when the body
does not efficiently use the insulin that is produced (Punthakee et al., 2018). T2D is
diagnosed as having glycated hemoglobin (A1c) levels of ≥6.5 mmol/L and either a) a
fasting plasma glucose level of ≥ 7 mmol/L or b) two separate two-hour oral glucose
tolerance tests of ≥11.1 mmol/L (Punthakee et al., 2018). According to Diabetes Canada
(2021a), it was estimated that one in three (29%), or about 11 million, Canadians were
living with diabetes (Type 1, Type 2 diagnosed or undiagnosed) or pre-diabetes (a T2D
precursor diagnosed as having an A1c of 6.0-6.4 mmol/L) in 2020. Specifically, there
were roughly 3.77 million (10%) Canadians with diagnosed Type 1 or Type 2 diabetes in
2020, where is T2D made up 90 to 95% of that population. In Ontario alone, 4.5 million
people were living with diabetes or pre-diabetes in 2020. These all-inclusive Canadian
and Ontarian prevalence statistics are expected to increase to 13.5 million (32%) and 5.47
(33%) million, respectively, by 2030. In 2019, Canada ranked ninth globally in largest
diabetes-related total (direct and indirect costs) healthcare expenditure at $12.3 billion
USD for those 20-79 years old (International Diabetes Federation, 2019). In 2020,
diabetes cost the Canadian health care system an estimated $3.01 billion USD in direct
costs (e.g., hospitalization, medication, home care, outpatient care like dialysis; Diabetes
Canada, 2021).
The burden of diabetes is not just realized by the large-scale burden on our healthcare
system resources and economy, but also on an individual level. All-cause mortality rates
are double for Canadians living with diabetes, compared to those living without (LeBlanc
et al., 2019). Diabetes can shorten one’s lifespan by 5 to 15 years and triples the risk of
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cardiovascular disease hospitalization (Public Health Agency of Canada, 2011), and is
linked to 30% of strokes, 40% of myocardial infarctions, and 70% of all non-traumatic
leg and foot amputations (Hux et al., 2003). Every day, people with diabetes face difficult
realities due to increased risks of many health complications (including early death),
decreased quality of life, greater family burden, as well as financial, emotional, and
mental strains (Gonzalez et al., 2016; Harding et al., 2019; Houlden, 2018). A daily
diabetes treatment regimen and frequent medical appointments can be burdensome and
time consuming (e.g., one to two hours per day; Gonzalez et al., 2016; Nicolucci et al.,
2013). Diabetes self-management is directly and indirectly related to individual-level
financial burden as well. Canadians with T2D spend an estimated $1,200-$1,900 CAD
out-of-pocket each year on oral medications, in addition to other medical supplies (e.g.,
glucometer, glucometer strips, etc.; Diabetes Canada, 2021). Time spent driving to health
appointments, in addition to increased time on disability (i.e., 15% longer than people
without diabetes) can also result in financial losses (Diabetes Canada, 2018; Gonzalez et
al., 2016). The human burdens and strains stated here are not an exhaustive list, but do
illustrate some of the wide-ranging impacts of this debilitating chronic disease.

2.2 Management of Diabetes
2.2.1

Optimizing Type 2 Diabetes Care. Management plans and support

decisions should be made collaboratively between those living with T2D and their
healthcare team in order to optimize diabetes outcomes such as glycemic control
(Sherifali et al., 2018). Practitioners must consider individualization as there are many
aspects that play into treatment decisions (Sherifali et al., 2018). For example, several
social determinants of health influence both an individual’s ability to engage in healthy
behaviours and their T2D disease management/progression (Houlden, 2018). These
determinants include, but are not limited to socio-economic status, ethnicity, environment
(e.g., unsafe neighbourhood, no sidewalks), education level, income, food security, social
connectedness, community resources, childhood development, and social stigmas
(Diabetes Canada, 2018; Houlden, 2018). Examples of social stigmas related to diabetes
can be (a) people assuming that the cause of T2D was the fault of the person’s
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behaviours; (b) persons with T2D reporting claims of discrimination against T2D; and/or
(c) persons with T2D feeling embarrassment or are ashamed to let people know they have
diabetes (Diabetes Canada, 2018; Horigan et al., 2017). To optimize T2D management
and minimize health inequities, these social determinants of health along with culture,
health beliefs, as well as ability/readiness for health change, must be considered when
individualizing T2D management plans (Diabetes Canada, 2018; Sherifali et al., 2018).
Overall, it is evident that there are a multitude of factors required to properly manage
each person’s unique journey with T2D. Therefore, patients require individualized
treatments and knowledge/skills training that incorporate care around medical, emotional,
and behavioural topics of diabetes self-management.
2.2.2

Type 2 Diabetes Mellitus: The Role of Self-Management.

Chronic disease self-management can be defined as the active participation in selfmonitoring of symptoms, making informed treatment decisions, and/or performing
complex activities needed for self-care (Chodosh et al., 2005; Sherifali et al., 2018).
When it comes to T2D self-management specifically, it is often described as an ‘around
the clock, full time job’ that requires a certain level of health literacy and numeracy, as
well as decision-making and problem-solving skills to achieve optimal glycemic control
Diabetes Canada, 2018; Gonzalez et al., 2016; Sherifali et al., 2018). Optimal glycemic
control is essential to the management of T2D and is associated with slowing the
progression of T2D and decreasing T2D-related microvascular (e.g., neuropathy) and
macrovascular (e.g., stroke) complications (Imran et al., 2018). Other outcome goals of
successful T2D management include increased quality of life, treatment self-efficacy, and
long-term functional capacity (Berard et al., 2018; Diabetes Canada, 2018; Sherifali et
al., 2018).
According to Diabetes Canada’s most recent Clinical Practice Guidelines (2018) and the
ABCDES of Diabetes Care Guide (Diabetes Canada, 2021b), T2D self-management
includes the following: glycemic control monitoring, regular exercise, decreased
sedentary time, healthy eating, weight management, medication adherence, foot care,
mental health management, and regular surveillance of T2D complications (which may
include self-awareness and regular screening for neuropathy, retinopathy, gum disease, or
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chronic kidney disease, etc.). Other guideline targets such as a blood pressure of <130/80
mmHg, cholesterol targets LDL-C of <2.0 mmol/L, drugs to reduce cardiovascular risks,
smoking cessation, management of stress, and mental health (or other barriers that can
prevent optimal targets) also need to be addressed (Diabetes Canada, 2021b).
2.2.3

Type 2 Diabetes Mellitus: Management Pillars. Overall, proper medication

adherence, nutrition, exercise, and glycemic monitoring should be highlighted as they
play as key diabetes management pillars and should be considered as a front-line
treatment rather than as a second-line defense, as these have the largest effects on glucose
control, such as lowered A1c levels (Berard et al., 2018; Colberg et al., 2010; Colberg et
al., 2016; Marçal et al., 2020; Sievenpiper et al., 2018; Sigal et al., 2018). Controlled A1c
levels, or levels ≤7% are linked with significant reductions in macrovascular and
microvascular risks (Imran et al., 2018). A1c targets of ≤6.5% can result in risk reduction
for retinopathy and chronic kidney disease (Imran et al., 2018). A1c targets should be
individualized and will vary, depending on other health conditions, goals and age (Imran
et al., 2018).
2.2.3.1

Medication Adherence. Medication adherence for people with T2D is an

important element in managing the progression of the disease and can result in reduced
mortality, hospitalizations, and healthcare costs (Khunti et al., 2017; Kirkman et al.,
2015). Despite benefits of optimal T2D control with regular medication adherence, many
fail to maintain regularity in taking medication (Gonzalez et al., 2016). In some cases,
non-adherence may be related to having to take multiple medications or certain
medications causing unwanted side-effects or requiring calculations, titrations, and/or
multiple doses (Lipscombe et al., 2018). Out-of-pocket costs, younger age, recent
diagnosis, or multiple medications can also threaten medication adherence (Kirkman et
al., 2015).
2.2.3.2

Nutrition. Nutrition is a key player in reducing overall A1c. Studies have

reported that nutrition therapy can result in 1-2% reductions in A1c levels (Sievenpiper et
al., 2018). Additionally, proper nutrition, timing of meals, and low glycemic index food
can assist in lowering glucose variability throughout the day (Sievenpiper et al., 2018).
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High glucose variability is linked to increased cardiovascular risks and microvascular
complications (Ceriello, 2020). Nutrition should be individualized and meet the
preferences of the patient to create long term, sustainable habits that are adhered to
(Sherifali et al., 2018; Sievenpiper et al., 2018).
2.2.3.3

Physical Activity: A Cornerstone of Type 2 Diabetes Management. There is

overwhelming evidence to suggest that higher physical activity levels have greater
protective effects against all-cause mortality and the incidence/mortality risks among
patients with several non-communicable diseases (Warburton & Bredin, 2017; Zhao et
al., 2020). These include cardiovascular disease, multiple types of cancers, chronic
respiratory tract diseases, T2D, hypertension, ischemic heart disease, and strokes
(Warburton & Bredin, 2017; Zhao et al., 2020).
Overall, higher physical activity levels, as well as engagement in aerobic and resistance
exercise, are critical to controlling and slowing T2D progression and the development of
co-morbid conditions (Sigal et al., 2018). Benefits include decreases in A1c, systolic
blood pressure, triglycerides, waist circumference, depression and anxiety symptoms, as
well as increases in glycemic control, quality of life and immune responses (Bull et al.,
2020; Chudyk & Petrella, 2011; Gupta et al., 2020; Myers et al., 2013; Umpierre et al.,
2011). In general, exercise has a contraction-mediated glucose uptake effect, distinct
from the insulin-mediated pathways (Colberg et al., 2010; Khayat et al., 2002). In those
with insulin resistance (i.e., T2D) this is particularly beneficial, as a person can increase
skeletal muscle glucose uptake (without the need for endogenous insulin) and
subsequently decrease current glucose levels (and several hours post-exercise; Colberg et
al., 2010).

In order to best achieve these benefits, the most recent Diabetes Canada Clinical Practice
guidelines (Sigal et al., 2018) and American Diabetes Association (ADA) guidelines
(Colberg et al., 2016) recommend a minimum of 150 minutes or more of moderate to
vigorous physical activity each week, with no more than two consecutive days without
aerobic exercise (i.e., walking, jogging, cycling, swimming, etc.) or resistance training.
Aerobic exercise of higher intensities (Liubaoerjijin et al., 2016) or longer than 150
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minutes of moderate to vigorous physical activity (Umpierre et al., 2011) have been
found to be associated with greater reductions in A1c, compared to less intense exercise
or 150 minutes or less of moderate to vigorous activity, respectively (Colberg et al.,
2016; Sigal et al., 2018). Resistance training alone is beneficial for diabetes because it
can increase insulin sensitivity (Jorge et al., 2011). Three sets of approximately eight
repetitions utilizing major muscle groups at a frequency of three times per week
(Castaneda et al., 2002; Dunstan et al., 2002) or more (Cauza et al., 2005; Durak et al.,
1990) have shown the greatest improvements in A1c (using free-weights or machines;
Sigal et al., 2018). The combined effects of engaging in both aerobic and resistance
exercise training result in significant improvements in A1c, compared to either aerobic or
resistance training alone (Pan et al., 2018; Sigal et al., 2007). One RCT including 251
adults with T2D reported that training in either aerobic or resistance training 3 times per
week for 22 weeks resulted in a mean (95% confidence interval [CI]) reduction in A1c of
-0.51% (-0.87 to -0.14) and -0.38 % (-0.72 to -0.22), respectively, when compared to a
control group (Sigal et al., 2007). However, combined effects of resistance and aerobic
training compared to either aerobic or resistance training alone, resulted in a further mean
reduction in A1c of -0.46% (-0.83 to -0.09) and -0.59% (-0.95 to -0.23), respectively
(Sigal et al., 2007). Although physical activity does come with increased risk of
hypoglycemic or cardiac events, typically the benefits of physical activity outweigh the
negatives (Bull et al., 2020), and there is low risk of adverse events with low- to
moderate-intensity physical activity engagement (Colberg et al., 2016).
On the lightest end of the physical activity spectrum, is sedentary behaviour, a behaviour
indicated by any waking activity in a seated, lying or reclining position (≤1.5 METs)
(Tremblay et al., 2017). Physical inactivity, in contrast, is another distinct behaviour.
Physical inactivity is defined as “an insufficient physical activity level to meet present
physical activity recommendations (Trembley et al., 2017, p.10). High sedentary time is
linked to increased risk of early mortality in the general population and those with
diabetes, even after controlling for moderate to vigorous physical activity levels (Sigal et
al., 2018). Both Diabetes Canada Clinical Practice Guidelines (Sigal et al., 2018) and the
ADA (Colberg et al., 2016) recommend to decrease and break up daily sedentary
behaviour, replacing it with standing or light physical activity every 20 to 30 minutes.

12

Evidence shows that interrupting prolonged bouts of sitting with light and/or moderate
physical activity has positive effects on glucose, post-prandial glucose, insulin and
triacylglycerol levels, and waist circumference in many different populations, with the
greatest benefits to sedentary people with T2D (Dempsey et al., 2016; Dunstan et al.,
2012; Healy et al., 2008; Loh et al., 2020). Dempsey and colleagues (2016) conducted a
three-armed crossover RCT in an inactive sample living with overweight/obese and T2D
and compared the effects of uninterrupted sitting, sitting plus three-minute bouts of light
walking, and simple resistance activities (i.e., half-squats, calf raises), every 30 minutes
on metabolic outcomes. Both three-minute bouts of activity types resulted in significant
decreases on the incremental areas under the curve for glucose, insulin, and C-peptide
levels. Only simple resistance activities significantly decreased triglycerides. This style of
activity, in populations that are sedentary, physically unable to, unwilling to, or struggle
with adhering to exercise, can be used as a practical steppingstone towards increasing
activity (Colberg et al., 2016; Dempsey et al., 2016).
2.2.3.4

Glycemic Monitoring. Glycemic monitoring is crucial to preventing

abovementioned complications of sub-optimal glycemic control related to T2D.
Glycemic monitoring is typically completed by both testing A1c every three months and
self-monitoring of blood glucose (with frequency individually prescribed by physicians;
Berard et al., 2018). Continuous or flash glucose monitoring can also be used to selfmonitor glucose levels (Berard et al., 2018). Self-monitoring requirements of glucose
varies from person to person, depending on type of diabetes, insulin or other antihyperglycemic medications, numeracy and literacy skills, and hypoglycemic awareness
(to name a few; Berard et al., 2018). When combined with structured education and
behaviour change programs, glycemic monitoring can result in improved glucose levels
and frequency of hypoglycemia (Berard et al., 2018). Glycemic monitoring can also be
used to support behaviour change when it comes to nutrition choices and participation in
exercise, utilizing biofeedback as a learning experience and positive reinforcement
(Berard et al., 2018; Ryan & Deci, 2000b).
2.2.4

Sustaining Type 2 Diabetes Management with Education.

DSME can be defined as a systematic intervention of facilitating knowledge, skills, and
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abilities required to actively participate in self-monitoring of symptoms, make informed
treatment decisions, and/or perform complex activities needed for self-care (Chodosh et
al., 2005; Sherifali et al., 2018). DSME should: be based on evidence-based standards;
address patient preferences, needs, goals and experiences; support problem solving skill
development; and be fostered by patient-healthcare team collaboration and interaction,
with the end goal of independent and effective, sustained self-care (Al-Khawaldeh et al.,
2012; Powers et al., 2015; Sherifali et al., 2018). These educational opportunities should
also cover topics about, and how to (i.e., behaviour change techniques), implement
proper nutrition, physical activity and glucose monitoring (Sherifali et al., 2018).
Despite benefits of DSME, people with diabetes may experience personal barriers to
attending DSME sessions. For many, socioeconomic status can play a large factor such as
lack of reliable transportation (e.g., unable to afford a personal vehicle) and/or financial
costs of attending (time taken off work, potential need to hire help for child supervision;
Horigan et al., 2017; Zgibor & Songer, 2001). Time can also be a large barrier, due to the
inability to travel far distances (e.g., no vehicle, rural location) or take time off work
(Horigan et al., 2017). Mental health, psychological disorders/factors (i.e., depression,
anxiety, borderline personality disorders), and emotions may also play into a role in
barriers to attendance (such as heightened anxiety about condition, denial, shame, fear of
excessive demands, and negative feelings towards groups or diabetes education)
(Gonzalez et al., 2016; Horigan et al., 2017; Robinson et al., 2018). Thus, virtual delivery
of group education sessions may address some of these barriers (e.g., remove need for
travel, cutting down on overall time needed for in-person attendance, etc.). Although
technology provides the potential to leverage efficient delivery of DSME for both
patients and clinical practice settings (i.e., video conferencing delivery), there is potential
for further marginalization of disadvantaged populations with limited resources (due to
socioeconomic status, access to internet, national healthcare policies/insurance plans etc.;
Faghy et al., 2021; Kang et al., 2021). This marginalization has only been exacerbated by
the COVID-19 pandemic (Misra & Bloomgarden, 2020). It is important to note that not
all persons may benefit from a virtual delivery of education sessions (Maddison et al.,
2019). Method of delivery should be determined via patient preference to maximize
attendance rates (Maddison et al., 2019). Current evidence suggests that technologies that
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support Internet (or “web-based”) DSME interventions (Arens et al., 2018), smartphone
DSME interventions (smartphone health apps or SMS text messages) (Li et al., 2020),
and wearable technologies may assist in supporting diabetes self-management (e.g.,
glucose monitoring; Kamei et al., 2020; Majithia et al., 2020; Sigal et al., 2018; van
Ommen et al., 2017) and result in improved glycemic control (Sherifali et al., 2018).
Therefore, utilizing these tools in addition to traditional DSME practice can maximize
accessibility and meet patients’ needs/preferences.

2.3 Wearable Devices: A Boost for Diabetes Self-Management?
Wearable devices (such FGMs and wearable activity monitors) have the ability to
increase capabilities and self-efficacy in diabetes self-management (Sherifali et al., 2018;
Sigal et al., 2018; van Ommen et al., 2017) and can be useful in facilitating behaviour
change (Patel, Asch, & Volpp, 2015). Wearable devices have been linked to lower A1c
levels (Quinn et al., 2011; Veazie et al., 2018), indicating general improvements in
diabetes self-management. They have become more user friendly, prevalent, and
affordable, which presents an opportunity to make diabetes care more inclusive and
effective (van Ommen et al., 2017). The ability to share medical and lifestyle data (i.e.,
glucose levels, step counts, meals etc.) with healthcare practitioners either remotely
(synchronous or asynchronous) or at an appointment can greatly benefit DSME and
increase motivation, improve feedback accuracy, and allow healthcare practitioners to
reinforce behavioural changes (Michaud et al., 2021; Rollo et al., 2016).
Wearable Activity Monitors. Wearable activity monitors (e.g., FitBit® or Apple
watch®, or Garmin®) have risen in popularity globally (Lamkin, 2016), which may
suggest that many people are interested in taking control of their health if it is made
accessible to them. Wearable activity monitors can be described as, “any device designed
to be worn on the user’s body, using accelerometers, with or without altimeters or other
sensors to track the wearer’s movements and/or biometric data, and with or without the
possibility to upload activity data to an online application that shows trends over time”
(Davergne et al., 2019, p. 759). Several studies have found increases in physical activity
and/or step counts when using wearable activity monitors as a form of self-monitoring in
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healthy populations (Brickwood et al., 2019; Goode et al., 2017; Lynch et al., 2020)
people living with overweight/obesity (de Vries et al., 2016; Fawcett et al., 2020), and
people with T2D or other metabolic diseases (Kirk et al., 2019; Kooiman et al., 2018).
One meta-analysis (n=28) investigated the effects of a wearable device on physical
activity levels in adult populations with cardiometabolic diseases (45% of studies with
samples with T2D and 28.6% with overweight/obesity) (Kirk et al., 2019). Meta-analyses
found statistically significant changes in the intervention group for steps per day (MD =
2592 steps/day; 95% confidence interval [CI]: 1689-3496) and moderate to vigorous
physical activity (MD = 36.31 min per week; 95% CI: 18.33-54.29). Wearable activity
monitors track daily step counts, minutes of physical activity and offer hourly reminders
to move amongst other features. For example, FitBit®, can offer reminders or “nudges”
to break sedentary behaviour (e.g., “Almost there! Keep moving to get your 250 steps for
this hour”). Nudges have been used successfully in interventions involving people with
T2D (Kullgren et al., 2017). The FitBit® and Apple Watch® models often feature an
animation to celebrate when the daily step goal is achieved, offering positive
reinforcement to further behaviour change (Bandura, 1998).
2.3.1

Wearable Glucose Monitors. Continuous glucose monitoring and flash

glucose monitoring are still relatively new, though are increasing in popularity. As of
2019, the continuous glucose monitor (CGM) market was valued at 4.24 billion (Market
Study Report, 2020). Currently, there is only one FGM on the market, which is the
FreeStyle® Libre (Abbott Laboratories Ltd., Illinois, United States). Both CGMs and
FGMs are small, wearable disk-like interstitial glucose sensors that can be worn on the
skin (usually the upper arm) for 7 to 10 days or 14 days, respectively (Beck et al., 2017;
Edelman et al., 2018; Diabetes Canada, 2020a; Heinemann & Freckmann, 2015). There
are differences between CGM and FGM. CGMs require finger-prick calibration and can
send continuous information to linked apps or readers, as well as provide alerts about outof-range glucose levels (Berard et al., 2018). The FGM requires no finger-prick
calibration and requires a person to actively scan (“flash”) the sensor once at least every
eight hours to transmit the past eight-hours’ worth of data (in 15-minute increments) to a
smartphone or reader (Berard et al., 2018; Diabetes Canada, 2020a). Further, these
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technologies can reduce self-management barriers, such as the traditional painful fingerstick blood samples, which has lower adherence than CGM/FGM, and result in poor
glycemic outcomes (Shan et al., 2019). These sensors offer timely, individualized
feedback that has shown to significantly reduce A1c levels and glycemic variability and
increase self-monitoring frequency, treatment satisfaction, and quality of life compared to
traditional self-blood glucose monitoring (Aberer et al., 2021; Berard et al., 2018; Cosson
et al., 2009; Evans et al., 2020; Hermanns et al., 2019; Shan et al., 2019). Hereafter,
FGMs will primarily be referred to, as this was the sensor used in this intervention
(though CGM evidence will also be referred to as needed).
2.3.2

Wearables Supercharged? The combined, complementary use of FGMs and

wearable activity monitors can be used as an instant-biofeedback mechanism can
counteract people’s tendency to prefer immediate over delayed gratifications (e.g., using
positive biofeedback that displays immediate effects of physical activity on glucose
levels verses the promise of lower cardiovascular risks in 25 years from daily exercise)
(Liao et al., 2020; Rabin & O’Donoghue, 1999). Likewise, instant biofeedback from
CGM and FGMs has the potential to help participants draw stronger links between
lifestyle health behaviour choices (i.e., food and exercise) and patterns in their glucose
responses (Allen et al., 2008; Liao et al., 2020; Whelan et al., 2019). The combined
educational experience of utilizing both FGM and wearable activity monitors may also
help participants to develop a deeper understanding of their self-management behaviours
(Hermanns et al., 2019). It may increase perceived feelings of control over and
confidence in, managing their chronic disease (Hermanns et al., 2019). This may be
explained in part by of the social-cognitive theory, which states that task performance
outcomes are linked to beliefs of self-efficacy and perceived control (Bandura & Wood,
1989). As well, according to SDT, positive performance feedback enhances levels of
competence (Ryan & Deci, 2000a). Increased confidence in abilities (self-efficacy) and
perceived control (fostered by evidence of change from biofeedback) are suggested to
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result in successful diabetes management and improved glycemic control (Gonzalez et
al., 2015; Gonzalez et al., 2016).
2.3.3

The Smartphone Hub. Often, wearable monitors are linked with

associated smartphone apps or Internet accounts. Diabetes-related smartphone health
apps offer comprehensive features, including health education, skill building, glucose
monitoring, weight management, dietary intake tracking, health coaching and/or
automated responses, and peer support groups (Koot et al., 2019; Shan et al., 2019).
These features can increase patients’ diabetes knowledge, social connectivity, and
management self-efficacy, resulting in glycemic outcome improvements (Kebede &
Pischke, 2019). Previous interventions have successfully used smartphone apps, with or
without the incorporation of wearable technologies, in in-person or virtual DSME
interventions (Arens et al., 2018; Hilmarsdóttir et al., 2020; Khanh et al., 2020; Staite et
al., 2020).

2.4 Theory-Based Diabetes Self-Management Interventions
When it comes to achieving optimal diabetes management outcomes, behaviour is the
lynchpin (McSharry et al., 2020). Behaviour change theories, such as SDT, provides a
framework that identifies key factors to target behaviour change that can be used to
inform diabetes care delivery and intervention content development (McSharry et al.,
2020). Additionally, SDT and other theories can explain/evaluate the efficacy of diabetes
health-behaviour targeted interventions (Halvari et al., 2017; McSharry et al., 2020;
Shigaki et al., 2010) and other health behaviour changes (e.g., physical activity, smoking
cessation, healthy eating etc.) in other populations (Sheeran et al., 2020). One review of
systematic reviews and meat-analyses (n=8) investigated the efficacy of theory-based
interventions on adult health behaviour changes activity (Dalgetty et al., 2019). This
review reported that two of the meta-analyses concluded that interventions that
specifically used SDT were associated with greater efficacy for interventions targeting
diet or physical activity (Dalgetty et al., 2019). The Diabetes Canada’s Clinical Practice
Guidelines (2018) specifically recommend informing exercise interventions with theory,
and mention the SDT, in order to increase exercise engagement (Sigal et al., 2018).
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Emerging evidence suggests that SDT-informed health behaviour change interventions
can be supplemented with use of specific BCTs in populations with T2D, such as goal
setting and self-monitoring (Fredrix et al., 2018; McSharry et al., 2020; McSharry et al.,
2016; Ntoumanis et al., 2020)
It is well known that the main goal of health behaviour change is long-term maintenance.
In general, autonomous motivation is a key factor for long term behaviour change, as
well as for increased healthy behaviour engagement, persistence, and overall well-being
(Ryan & Deci, 2000b; Ryan et al., 2008). Among patients with T2D, studies have found
that levels of autonomous motivation and perceived competence can modulate diabetes
self-management behaviours (Williams et al., 2004) and predict medication adherence
(Williams et al., 2009). Higher levels of autonomous motivation for diabetes selfmanagement activities are related to higher frequencies for diet and blood glucose testing
(Shigaki et al., 2010) and decreased A1c levels (Williams et al., 2004).
Autonomous motivation for health behaviour changes can be supported using the SDT.
SDT is a general theory of motivation (Figure 1). Under the health-related behaviour
change lens, SDT focuses on the processes of personal and contextual motivational

Figure 1. An adaptation of Ryan and Deci’s Self-Determination Theory (p. 1010) (Cook
& Artino, 2016)

19

factors behind health behaviour initiation all the way to sustained engagement (Ryan &
Deci, 2017; Ryan et al., 2008). In the health domain, personal factors such as types of
motivation and psychological needs have been specifically targeted in experimental
interventions. One of the strengths of SDT is that it offers flexible processes (i.e.,
autonomy, relatedness, competence) that can be targeted in any health behaviour change
intervention (Fortier et al., 2007).
Motivation is a multifaceted concept; it can be distinguished into different types of
regulatory styles when considering the underlying factors that result in engaging in a
behaviour (Ryan & Deci, 2000b). Motivation lies on a continuum of self-determination
(or autonomy; Ryan & Deci, 2000b). On one end there is amotivation, where there is no
motivation to engage in, and no regulation of, the behaviour. On the other, there is
intrinsic motivation, where actions are done out of enjoyment and pleasure and
intrinsically regulated; Ryan & Deci, 2000a, 2000b, 2017). In the middle of the spectrum
lies extrinsic motivation. Extrinsic motivation can be an array of regulatory styles based
on levels of self-determined autonomy (Ntoumanis et al., 2020; Ryan & Deci, 2017).
First, external regulation is the least self-determined extrinsic motivation; a person will
engage in the behaviour passively, typically to appease external demands or to satisfy a
reward contingency (Ryan & Deci, 2000a). Introjected regulation is the second type of
extrinsic motivation. This internalized regulation is still heavily controlling, as people act
to satisfy contingent self-esteem (i.e., self or other’s approval) and/or to avoid guilt or
anxiety (Ryan & Deci, 2000a). Identified regulation is the third extrinsic motivation,
where there is a conscious valuing and endorsement of behaviours and their outcomes
form these motivations (Ryan & Deci, 2000a, 2000b). Lastly, integrated regulation (the
most self-determined of external motivation) occurs when behaviours are acted on when
there is alignment with core values and identity, and the person accepts self-regulation
(Ryan & Deci, 2000a, 2017).
The process of internalization and integration of health-related behaviours explain the
progression of increasing levels autonomous motivation (through various regulation
styles) (Ryan & Deci, 2000a). Notably, there is no specific sequence of progression
(Ryan & Deci, 2000a). SDT recognizes that different life experiences and factors may
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place people in different stages of motivation levels initially and can move either
“forward” or “backward” in self-regulation (Ryan & Deci, 2000a). Though, generally
people progress towards higher levels of intrinsic motivation and internal regulation
(Ryan & Deci, 2000a).
SDT also focuses on three key psychological factors: need for autonomy (a sense of
control or choice of a behaviour), competence (a sense of mastery, feeling competent or
confident), and relatedness (sense of belonging, accepted by, connect with others)
(Ntoumanis et al., 2020; Ryan & Deci, 2017; Ryan et al., 2008). SDT posits that in any
healthcare environment, it is critical that a person experiences feelings of both autonomy
and competence in order to foster internalization and integration of health-related values
and skills (Ryan et al., 2008). These processes can lead to increased self-regulation,
enhanced adherence, and sustained healthy behaviour engagement (Ryan & Deci, 2000b;
Ryan et al., 2008). A sense of relatedness is also a key aspect to internalization: a person
is more likely to adopt values and behaviours promoted by figures that they trust and feel
connected with (Ryan et al., 2008). Interventions that target increasing psychological
needs satisfaction will modulate levels of perceived confidence and autonomous
motivation, which in turn fosters self-determined motivation and increases healthy
behaviour engagement (Halvari et al., 2017; Ng et al., 2012; Ntoumanis et al., 2020;
Ntoumanis et al., 2017; Shigaki et al., 2010). Overall, since T2D is a chronic disease,
motivation to engage with the lifelong journey (or process) may be more important in
diabetes self-management treatment, rather than a specific treatment or outcome goal
(Shigaki et al., 2010), and consequently, should be targeted.

2.5 A Call to Action for Diabetes Management
On March 11, 2020, the World Health Organization declared the COVID-19 virus
outbreak as a global pandemic. The COVID-19 virus has now infected over 167.5 million
people worldwide (as of May 24, 2021; worldometers.info/coronavirus). Populations with
non-communicable diseases, such as those with T2D, are at increased risk of more severe
cases of, and mortality from, a COVID-19 infection (Apicella et al., 2020). Fortunately,
good glycemic control is linked to lower mortality rates and disease complications
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(Stefan et al., 2021; Zhang et al., 2021). As part of the measures taken to limit the spread
of the COVID-19 virus, many people are staying home and pausing usual activities.
Evidence shows that glycemic control in people with T2D has significantly deteriorated
as a result (Marçal et al., 2020). This metabolic deterioration is likely attributable to
increased stress and anxiety levels, decreased physical activity levels, increased sedentary
behaviour, and unhealthy eating patterns (Marçal et al., 2020). Longer or more extreme
forms of isolation are expected to futher exacerbate the detrimental effects of physical
inactivity and deconditioning (Marçal et al., 2020). Increasing amounts of literature are
supporting the urgency and clinical importance of making physical activity as one of the
cornerstone practices for COVID-19 infection severity and risk management for people
with T2D (Faghy et al., 2021; Marçal et al., 2020), along with general diabetes
progression (Sigal et al., 2018). Many community and clinical-based DSME programs
have had previous success in assisting with an uptake of healthy behaviour changes
(physical activity and nutrition) resulting in promising glycemic, cardiometabolic, and
weight loss outcomes (Castillo et al., 2010; Wayne et al., 2015; Wing & Look Ahead
Research Group, 2010). Although, traditional DSME has been typically offered in-person
or mostly in person, current literature suggests that DSME and support delivered through
a virtual platform may be a feasible alternative for both those with T2D and educators
(Clement et al., 2018; Sherifali et al., 2018). The need for accessible, effective virtual
delivery of DSME has never been more important than during this pandemic, and heavy
demands for rapid innovations in technology, healthcare and interventions may offer an
accelerated path towards the future of a promising virtual diabetes care setting.

2.6 Virtual Care
The “new normal” in the COVID-19 pandemic has sparked a revolution in the healthcare
world, offering unparalleled opportunities for quick real-world application and testing of
new technologies, type of care, and interventions (Agarwal et al., 2021). As a result,
virtual patient/provider group videoconferencing platforms (i.e., Zoom, WebEx etc.,) and
virtual care technologies are being adopted and used at unprecedented rates, thereby
increasing the demand for rapid improvements, creations of, and supply for innovative
digital health technologies (Agarwal et al., 2021). Systems offering automated decision-
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making software, remote-monitoring technologies (such as wearable monitors), multiple
medical devices (i.e., insulin pens, FGMs, etc.), and rapid data analytics can be used to
optimize virtual and face-to-face diabetes care (Cafazzo, 2019; Phillip et al., 2021).
With the increased need for virtual consultations (delivered off-site using multiple types
of technology) due to COVID-19, the literature has become even more saturated with
multiple terminologies that can overlap each other (i.e., eHealth, telehealth, telemedicine,
uHealth, mHealth, remote monitoring etc.). The umbrella term of “virtual care” has been
chosen to refer aspects of previous and current published literature related to diabetes
care. Virtual care is an all-encompassing term and is defined as, “any interaction between
patients and/or members of their circle of care, occurring remotely, using any forms of
communication or information technologies, with the aim of facilitating or maximizing
the quality and effectiveness of patient care.” (Jamieson et al., 2015, p. 5). According to
Jamieson et al. (2015), virtual care does not refer to specific technology, actors (e.g.
patients, physicians), or data. Virtual care can for example include, remote monitoring or
patients, secure electronic messaging, teleconsultations, or videoconferencing visits.
2.6.1

Slow Traction, Inertia Laiden: Barriers to Virtual Delivery.

Previous studies have tested testing multiple mediums of delivering both general diabetes
care and DSME virtually, typically though either teleconsultation (most often),
smartphone health app, or Web-based app interventions (Bergenstal et al., 2021;
Kooiman et al., 2015; Kato et al., 2020; Lystrup et al., 2020). Additionally, many
researchers have attempted to incorporate technologies such as wearable activity
monitors, Bluetooth weighscales, and/or apps to manually input steps, glucose readings,
and/or food (Shan et al., 2019). Though often, at the time of trial completion, and even
more so, publication, many of these technologies were already replaced with bigger and
better versions, and thus quickly irrelevant (Cafazzo, 2019). Multiple articles have reported inertia in the movement to a fully integrated, virtual diabetes care model, despite
large amounts of evidence for potential for improvements in standards of care and
multiple patient outcomes (Aberer et al., 2021; Cafazzo, 2019; Phillip et al., 2021). This
has been attibuted to several factors. One, there have been issues with extreme lack of
interoperability between third-party wearables, electronic health records, diabetes
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technology platforms (creating data “silos”; Zhang et al., 2021), and type of data being
transferred (e.g., cut and paste method; Phillip et al., 2021). Two, there have been
insufficient patient and healthcare practitioner infrastructure, insufficient healthcare
practitioner reimbursements systems, patient insurance coverage (Phillip et al., 2021),
and/or regulatory limitations with data sharing (Aberer et al., 2021). Three, patient or
healthcare practitioners may lack self-efficacy or technological skills, well as the time,
effort, or literacy required to learn them (Cafazzo, 2019; Zhang et al., 2021). Finally,
there is the potential for extra burden on patients (Rollo et al., 2016), challenge with
clinical trial to real-world implementation, and the potential for workforce burn out due
to its time-consuming nature (such as continuous monitoring, multiple data input, data
saturation, or patients’ reliance on healthcare practitioners for support and interpretation
etc.; Agarwal et al., 2021; Sim & Lee, 2021). The increased demand for comprehensive
virtual care technology in response to the COVID-19 pandemic has opened up an
opportunity to accelerate this inertia-laiden, pre-existing transition towards use of virtual
diabetes care delivery (Agarwal et al., 2021; Zhang et al., 2021). Already, the COVID-19
pandemic virtual care transition has influenced workflows and technology infrastructure,
as well as national/provincial healthcare reimbursement policies in a positive direction
(Zhang et al., 2021).

Virtual Diabetes Self-Management: Always Evolving. Previous virtually
delivered diabetes management interventions, with or without wearable technology,
suggest promise of positive results in healthy behaviour changes (i.e., increased physical
activity) and glycemic outcomes, and in some cases, larger improvements compared to
traditional face-to-face (Komkova et al., 2019; Li et al., 2020; Ward et al., 2018; Wolever
et al., 2010). Recently, a meta-analysis investigating the effects of wearable devices used
in virtually delivered health interventions in chronic disease populations (cardiac
diseases, T2D, and chronic obstructive pulmonary disease) was conducted (Kamei et al.,
2020). A T2D sub-analysis reported a significantly higher number of participants with a
weight loss of >2% from baseline weight (a risk ratio of 2.2; 95% CI 1.38 to 3.5;
p=0.0009; I2=0%) to three months when using a wearable activity monitor with a
virtually delivered DSME program (specifically interventions using goal setting),
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compared to a wearable activity monitor alone. The authors of another meta-analysis
reported that the addition of remote feedback from wearables into standardized
treatments led to small to moderate increases in physical activity levels (which may be
particularly useful when direct supervision is not possible; Kongstad et al., 2019). A large
meta-analysis on 55 RCT’s described improvements in A1c levels (Hedge’s g= -0.48, p
<0.001) with virtual delivery which included either device-based remote monitoring
and/or any method of virtual consultation, compared to traditional face to face diabetes
care delivery (Su et al., 2016). Of the included RCTs, 22 significantly favoured the
virtual delivery groups, one the traditional delivery, and 32 reported no significant group
differences in reducing A1c (p<0.05). A recent meta-analysis pooling data from 15 RCTs
(from 2000 to 2017), reported modest decreases in A1c (a mean difference (95% CI) of .30% (-0.31 to -0.29%)) from virtual delivery compared to usual care (Michaud et al.,
2021). Subgroup analyses revealed that studies that included both remote monitoring with
automatic submission and real-time feedback as a part of the virtually delivered
programs, can result in greater decreases in A1c (a mean difference (95% CI) of -0.61 (0.65 to -0.56) and 0.77 (-0.82 to -0.72]), respectively. Their results demonstrate the
combination of remote monitoring technologies into lifestyle supportive, virtual DSME
programs can be beneficial and can potentially lead to decreased A1c levels. It is worth
commenting that the teleconsultations were likely one-on-one treatment, as none of the
descriptors in the narrative tables described any group-based interventions (Michaud et
al., 2021).
2.6.2

Identifying Gaps in the Literature. More intensive interventions combining

remote monitoring, behavioural counselling, and lifestyle medicine have also shown
promise in their feasibility and glycemic control outcomes (Gal et al., 2020; Hermanns et
al., 2019; Hickman et al., 2021; Hilmarsdóttir et al., 2020; Jiwani et al., 2021; Kato et al.,
2020; Kooiman et al., 2018; Majithia et al., 2020; Rawstorn, Gant, Meads, et al., 2016;
Taylor et al., 2019; Wada et al., 2020; Whelan et al., 2019; Whitehouse et al., 2020).
However, as technology continues to rapidly advance, there remains many identified
barriers of clinical implementation and gaps in the literature. Barriers of clinical
implementation can be related to high levels of patient reliance on healthcare practitioner
continuous monitoring (Majithia et al., 2020) or the time consuming nature of one-on-one
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counselling with healthcare practitioners (Kato et al., 2020; Wolever et al., 2010).
Particularly in the virtual DSME literature, there remains a lack of structured exercise
prescriptions and/or exercise experts (Jiwani et al., 2021; Kato et al., 2020; Majithia et
al., 2020). For example, a study conducted by Kato et al. (2020) between August 2016 to
January 2017, offered a relatively comprehensive, six-month remote exercise therapy
program to 53 men (mean age 54.4 ± 6.0 years) that combined Bluetooth wearable
activity monitors, sphygmomanometers, and body weight scale data onto an
automatically transmitted platform. Although the combined data platform was novel, the
study had some limitations. This study lacked a seminal part of diabetes selfmanagement: glucose monitoring. As well, there were bi-weekly 20-minute individual
food and nutrition coaching sessions led by a public health nurse. Over the course of 6
months, this type of protocol could potentially create undue workload when dealing with
many patients. The public health nurse provided one nutrition and exercise goal to be
achieved until the next appointment based on individuals’ transmitted data. However,
assigned goals have shown to decrease intrinsic motivation (Ryan & Deci, 2000b).
Lastly, a nurse, although knowledgeable in general exercise guidelines, could potentially
not be able to provide specific counselling or prescriptions to best optimize treatment
outcomes, unlike an exercise specialist (e.g., Registered Kinesiologist or Certified
Exercise Physiologist; Sigal et al., 2018).
Another pre-post single arm study with 594 participants (mean age 53.0 ± 8.4 years,
62.3% female) investigated participants’ attitudes towards use of CGMs and linking the
use of CGM to changes in A1c (Bergenstal et al., 2021). The intervention was a novel,
comprehensive virtual diabetes clinic that combined a smartphone app, remote
personalized lifestyle coaching (including health coaches, certified diabetes care and
education specialist) and CGMs. Glucose data from the CGMs were all reviewed by a
care team and used as a coaching tool to help patients associate glucose levels with
lifestyle choices (i.e., nutrition, exercise) to help optimize glycemic levels. At the 10 ±
4.0 month follow up period, there were significant reductions in A1c: -0.6% ± 1.5%
(p<0.001). Specifically, in insulin and non-insulin users with a baseline of A1c ≥8%, a
reduction of -1.5 ± 2.1% and -2.0 ± 1.7% (both p<0.001) was found, respectively.
Overall, it was also feasible to train participants to apply the CGMs over a completely
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virtual setting and was accepted by patients (4.5/5 mean satisfaction score). A few
limitations are noted. There appears to be a heavy reliance on interpretation and guidance
from practitioners by patients and only used one-on-one sessions. This could add
considerable amount of workload to practitioners, such as needing to both review data in
advance and constantly with patient and may create a dependence and/or low patient
ownership of T2D management. The intervention lacked wearable activity monitors,
which have considerable impact with self-monitoring and motivation to increase physical
activity (as previously mentioned; Brickwood et al., 2019; de Vries et al., 2016; Goode et
al., 2017; Lynch et al., 2020; Kirk et al., 2019; Kooiman et al., 2018). Although there
were health coaches as a part of this program, no specific exercise prescriptions or
exercise specialists were explicitly mentioned in this study.
Overall, workforce burnout and lack of staff or funding is a large concern for
sustainability of virtual care practices (Marzolini et al., 2021). Group education can
address some of these issues by offering the ability to target multiple patients at once, and
can be beneficial in increasing feelings of relatedness, social connectedness, and peer
learning (Deci & Ryan, 2015; Ryan & Deci, 2000b). Additionally, exercise specialists
should be included when working with chronic disease populations (who may also have
co-morbidities) and can help guide exercise prescriptions more effectively when working
with patients, compared to nurses or physicians (Colberg et al., 2016). Evidence suggests
that virtually delivered exercise cardiac rehabilitation programs can be at least as
effective as in person programs (Rawstorn, Gant, Direito, et al., 2016). One 12-week
RCT offered completely virtual, real-time one-on-one cardiac rehabilitation exercise
intensive sessions (using electrocardiogram and accelerometry monitoring devices) as a
part of a theory-based, behavioural change cardiac rehabilitation program (Maddison et
al., 2019). Results deemed their comprehensive remote delivery as an effective, costefficient alternative delivery model. Therefore, a more intensive exercise delivery for a
population with T2D has the potential to also be feasible.
To the author’s knowledge, there is only one study to incorporate a completely virtual
delivery of an intensive lifestyle medicine intervention that use FGMs and wearable
activity monitors for a T2D population (Jiwani et al., 2021). A focus group study
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conducted by Jiwani and colleagues (2021) included 18 older adults living with
overweight/obese and T2D (mean age 72 ± 5.4 years, 56% female), reported on the
participants’ experiences of a six-month pilot intervention. The pilot was a completely
virtual, group-based lifestyle medicine intervention that incorporated use of FGMs
(FreeStyle® Libre) and wearable activity monitors (FitBit® monitor). The authors
reported high levels program acceptability, retention (90%), participant-reported
increases in diabetes self-management knowledge and behaviour, and quality of life. The
study occurred during the midst of the initial phases of the COVID-19 pandemic and
provided information on how the intervention helped participants cope with social
distancing measures and disruptions to routines when it came to exercise and nutrition
behaviours. As well, they report themes of increased self-awareness of exercise and
nutrition behaviours and their link to health outcomes (which for some, lead to increased
feelings of competence). Unfortunately, as this was a comprehensive qualitative
synthesis, there were no basic quantitative outcomes reported (e.g., change in steps,
glycemic outcome) which are needed to move forward with a larger study. This program
also lacked the crucial feature of exercise specialist expertise and individualized exercise
prescriptions. Overall, evidence continues to build to support the development of
comprehensive technologies integrated into virtually lifestyle medicine programs.
However, there remains little evidence available on multi-component interventions that
deliver virtual, group-based lifestyle medicine programs that offer exercise prescriptions,
especially in populations with T2D.
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Chapter 3

3

Methodology

3.1

Study Design

To assess the feasibility of delivering a virtual multi-component group-based lifestyle
medicine program, a six-week single cohort feasibility study was conducted between
November 2020 and March 2021. Following Phase Ib (Treatment Refinement) of the
ORBIT model (Figure 1), the aim of this study was to define critical treatment
components (e.g., self-monitoring) and assess study acceptability (e.g., recruitment rates,
participant satisfaction), adapting the protocol as necessary (Czajkowski et al., 2015).
Methods to optimize treatment (i.e., testing different modes of program delivery) and
todetermine clinical relevancy on behaviour/physiological outcomes were also
investigated (Czajkowski et al., 2015). The study was registered at clinicaltrials.gov
(Identifier number: NCT04498819) and approved by Western University’s Health
Science Research Ethics Board (REB # 116071; Appendix A).

Figure 2. The ORBIT Model for Behavioural Treatment Development (p. 19)
(Czajkowski et al. 2015).
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3.2

Setting and Study Sample

The study was conducted at a London, Ontario diabetes outpatient clinic (the Primary
Care for Diabetes Support Program, hereafter referred to as the ‘diabetes clinic’). This
multidisciplinary diabetes clinic serves approximately 3000 patients at any given time,
with six to eight new patient referrals per week from London and surrounding areas
(Reichert et al., 2014). Adults (≥18 years old) who were new patient intakes, medically
diagnosed with T2D, able to communicate in English, and physician-cleared to exercise
were recruited. This study sought to recruit a convenience sample of 15 to 20
participants, a sample size used in similar studies (Dack et al., 2019; Jiwani et al., 2021;
Taylor et al., 2019; Whitehouse et al., 2020). Patients had to have access to the Internet
and a smartphone (i.e., iPhone 7 iOS of 12.2 or higher or Android (operating system 5 or
higher) to allow for FitBit® and LibreView smartphone app compatibility) to be eligible
to participate. Participants were excluded if they had an active or recent case of a foot
ulcer(s), unstable health conditions limiting exercise, were pregnant, or had an unstable
psychiatric disease that would limit participation in group education classes.

3.3

Recruitment

The full recruitment procedure is described in Appendix B. Briefly, all new patients at the
diabetes clinic were encouraged by physicians and nurse practitioners at their initial
intake appointment to attend a physician-led one-hour general lifestyle medicine class,
per usual care (in person and virtually, depending on Ontario COVID-19 pandemic
restrictions at the time). Upon completion of this one-hour class, prospective study
participants were recruited by a diabetes clinic physician to participate in this feasibility
study. Recruitment occurred between November 1, 2020, and January 31, 2021. Patients
expressing interest in the study were given a Letter of Information to review (Appendix
C). Concurrently, prospective participants were medically screened for safe exercise
participation using a modified version of the Physical Activity Readiness Questionnaire
(PAR-Q; Appendix D) previously used by the diabetes clinic (Freehan et al., 2018).
Those deemed eligible to participate in the study were then sent an email containing a
copy of the four baseline questionnaires (for advance review) and a video tutorial on how
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to use the WebEx® video communication platform (Cisco© Systems, Inc., San Jose,
California). The WebEx® platform is Health Information Protection and Privacy Act
(HIPPA) compliant. The informed consent process occurred via WebEx® or telephone
(according to participant preference), at which time technology eligibility requirements
were confirmed. Participants provided informed consent with their digital signature via a
secure, individualized REDCap (Harris et al., 2008) link. REDCap is a secure, web-based
database and online questionnaire program that was used to store study data. Patients who
did not wish to participate in the study continued to receive usual care (i.e., follow-up
appointments with primary care provider).

3.4
3.4.1

Lifestyle Medicine Program
In-Person Programming. Before the implementation of COVID-19

physical distancing measures, the diabetes clinic offered an optional in-person lifestyle
medicine program for their patients living with T2D. This 12-week program was
delivered bi-weekly in a semi-structured group format by a multidisciplinary clinical
team, including: Certified Diabetes Nurse Educators (CDNEs) (who are registered
nurses), nurse practitioners, registered dieticians, and/or physicians. Their group
education class structure typically followed: (a) individuals viewing their bi-weekly
FreeStyle® Libre glucose patterns (discussing the impact of sleep patterns, food intake,
medication adherence) and (b) general food (e.g., glycemic index or meal preparation) or
behaviour change (i.e., self-monitoring activity) topic discussions. This evidence-based
program used motivational coaching techniques (e.g., client discrepancy discerning,
expressing empathy, rolling with resistance etc.) (Markland et al., 2005) to promote
healthy living behaviours with a particular focus on lower carbohydrate diets
(Sievenpieper et al., 2018). The program also offered general advice to increase physical
activity and reduce sedentary behaviour (e.g., “Your goal is to get 150 minutes of
exercise each week.” or “Reduce your daily sitting time.”).
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3.4.2

Virtual Programming. The intervention is a modification of the existing

aforementioned in-person lifestyle medicine program. The virtual version of this multicomponent group-based lifestyle medicine program shared many of the in-person
program treatment components (i.e., glucose monitors, bi-weekly classes) (Figure 3) and
is summarized using the BCT Taxonomy (see Table 1). This taxonomy is used to identify

Figure 3. A summary of key intervention components.
“active ingredient” intervention components by standardized labels and definitions
(Michie et al., 2013). There were some key differences between the in-person and virtual
programs, and they are noted next. First, the program was offered almost entirely
virtually (i.e., bi-weekly group education classes via WebEx® videoconferencing
platform). Next, wrist-worn wearable activity monitors, the Fitbit Inspire 2™, were
loaned to participants. There were group technology orientation classes to assist with set
up of the FreeStyle® Libre and FitBit Inspire 2™ and ongoing technology assistance was
provided throughout the study. Third, physical activity education was given roughly
equal emphasis (vs. nutrition education only) during the bi-weekly group education
classes, with more problem-solving skill development included (e.g., developing exercise
mindfulness; see below for general topics covered and Appendix E for BCT-related
topics covered). As well, the intervention used the self-determination theory as the
framework for certain intervention components. Last, instead of only offering general
advice to increase physical activity, an exercise specialist (a kinesiology graduate and
certified personal trainer; Canadian Society of Exercise Physiology, under physician
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supervision)) provided participants with individualized exercise prescriptions. The
exercise specialist provided bi-weekly 10 to 15-minute one-on-one check-in phone calls
to provide exercise counselling (e.g., review daily step count goals, facilitate action
planning; Gillison et al., 2019; Schroe et al., 2020) The one-one-one phone call check-ins
with the exercise specialist was intended to increase individualization of advising,
agreeing on plans, and assisting with advice/resources, as some participants may be less
likely to want to share their plans with the class (Vallis et al., 2013).
Table 1. Identifying notable components of the virtual lifestyle medicine program, using
the behaviour change techniques (BCTs) taxonomy.
Intervention Components
BCT
Number
Label
1. Goals and Planning
1.1*
Goal Setting
(behaviour)
1.2
1.4*
1.5

Problem solving
Action planning

Intervention Component
Prompted participants to set goals at end of classes and during exercise
counselling calls. E.g., “what kind of food or activity goal would you
like to set for this week?”
Encouraged identifying barriers.
Encouraged detailing the specifics of how they were to achieve their set
goal or step count goal.
Encouraged asking self, “What went well, what didn’t? Do I need to
scale back or make it more challenging?”

Review
behaviour goals
2. Feedback and Monitoring
2.2*
Email summaries and phone discussions informed participants about
Feedback on
previous weeks’ activity. E.g., “You hit 9/14 days of your step count
behaviour
goal! I noticed you hit over 10,000 steps on 4 days last week.”
2.3*
Self-monitoring
Provided the FitBit Inspire 2™ to track daily step counts, hourly
of behaviour
movement goals (and exercise minutes, if desired).
2.4
Self-monitoring
Provided the FreeStyle® Libre to participants so that they may see the
of outcome(s) of
immediate effects of exercise and food choices on glucose.
behaviour
2.6
Using FreeStyle® Libre glucose readings as a learning tool to
Biofeedback
understand personal glucose responses to exercise and food, with the
goal of increasing healthy behaviour adaptations.
7. Associations
7.1*
Using FitBit Inspire 2™ reminders to get 250 steps/hour.
Prompts/cues

8. Repetition and Substitution
8.7*
Individualized step count prescriptions. Creating “easy to perform”
Graded tasks
tasks, making step count goals increasingly difficult, but achievable.
10. Reward and Threat
10.4
Congratulating participants on an achievement, regardless of size of
achievement. This was done via email or during one-on-one phone call
Social reward
check-in correspondence. E.g., “I saw that you hit 7000 steps on
Tuesday, which has been your highest daily step count yet! Amazing!”
*BCT that was not used as a part of the in-person version of the lifestyle medicine program (i.e., ‘new’
BCT)
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3.4.2.1

Virtual Class Format. Class learning material was founded on Diabetes

Canada Self-Management Education guidelines (Sherifali et al., 2018). Class topics and
materials were inspired and supplemented from other programs and studies (Jiwani et al.,
2020; Look AHEAD trial, 2008; Diabetes College™; Diabetes Canada; Duhigg, 2012).
Group classes were planned to flow based on patient questions, comments, or concerns.
The original aim was to not be didactic, but rather have a “conversation” led by patients’
questions and answers, with guiding input from the CDNE or exercise specialist
depending on the topic and question at hand.
A) Opener
After a quick icebreaker related to the previous week’s theme, the CDNE
congratulated participants on improvements in glucose readings from FreeStyle®
Libre reports. This was followed by nutrition and glucose topics (taught by the
CDNE), then exercise and coping strategies (taught by the exercise specialist). Each
class participants were provided with a worksheet to fill in their new exercise
prescription step goals, take notes, and create new goals and action plans.
B) Nutrition and Glucose Levels
This part of class was delivered previously at the diabetes clinic. Due to rolling intake,
each class reviewed briefly what carbohydrates, fats, and proteins are, as well as ideas
of meals that fall under a low carbohydrate diet. There were group discussion
opportunities to problem solve examples of glucose responses after types of meals and
review on how to understand glucose data (i.e., what numbers to look for, what arrow
trends meant, and how to read/understand glucose summaries/trends available in the
LibreLink app). The CDNE covered how to identify specific trends and fluctuations in
daily patterns. As well, the CDNE emphasized how “good” glucose trends, caused by
specific eating, exercise, stress, sleep, or medication at certain times of day, can be
used to figure out how to improve other areas from other times of the day. Broad
topics such as snacking, low carbohydrate habits, the glycemic index, healthy fats, fast
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food, and holiday eating were covered. Topics were closed by discussing their old
habits (related to the week’s topic), a new habit to consider adopting, how to reward
the habit, and types of strategies participants would consider using to implement these
new habits. These practices are in line with recommendations from the SelfManagement Education and Support 2018 Clinical Practice Guidelines: teaching how
to properly self-manage their diabetes, incorporating problem solving and selfmonitoring of health parameters, as well as numeracy sensitive materials into a
comprehensive self-management education program to improve self-efficacy,
numeracy and A1c (Sherifali et al., 2018).
C) Exercise
The exercise specialist led exercise discussions. Each week started out with brief
safety reminders, followed by a review of aerobic exercise and incidental/light activity
(the differences, recommended guidelines, and strategies on how to accumulate them
(and progress independently)). Participants were strongly advised to exercise for a
minimum of 5 to 10 minutes per bout, encouraging them to ideally progress up to a
minimum of 150 minutes per week or 30 minutes per day, 5 days a week at a brisk
walking pace at an RPE (or “Rating of Perceived Exertion”) of 3-6 which elicits a
moderate intensity (Sigal et al., 2018). Participants were strongly advised to not go
more than two days without any aerobic activity to avoid any excessive decline in
insulin action (Sigal et al., 2018). It was emphasized that the goal of the exercise
education was to give knowledge and facilitate self-management skills needed to
create and achieve individualized exercise goals, based on the individuals’ needs and
preferences (Sherifali et al., 2018). Strategies and recommendations were discussed on
how to accumulate their step counts: through exercise minutes (walking) and light
physical activity (messaged as: “movement throughout the day”). In class (and in oneon-one phone call check-ins), participants were encouraged to make a goal on how
they could accumulate their steps (e.g., how long the bouts will be etc.), and they were
advised to record them in their workbooks. These basic, recommended strategies and
information on exercise accumulation and progression were based off the Diabetes
Canada (Sigal et al., 2018) and Exercise and Diabetes: A Clinician’s Guide to
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Prescribing Physical Activity (Colberg, 2013), published by the American Diabetes
Association. Sedentary behaviour guidelines were sourced from Diabetes Canada
(Sigal et al., 2018) and the Canadian Society of Exercise Physiology’s 24-hour
Movement Guidelines. Other exercise topics covered were sedentary behaviour,
strength training, exercising and glucose responses (i.e., walking after a meal to
decrease blood glucose), behaviour substitution (e.g., replacing sedentary behaviour
for light physical activity), and exercise mindfulness/monitoring of emotional
consequences.
E) Coping and Problem Solving
The exercise specialist covered coping and problem-solving topics in relation to
exercise adherence, such as: working against negative thoughts, holiday guilt,
mindfulness, goal setting, action planning, barrier identification and problem solving,
tracking progress/self-monitoring of behaviours, building on success and failures,
relapse prevention, using social support, and prompts/cue to initiate behaviours
(Duhigg, 2012; Look AHEAD material, 2008; Jiwani et al., 2020).
F) Goal Setting and Action Planning and Closure
Participants would be sent off with encouragement for the next two weeks. Facilitators
emphasized at the end of each class that participants had a fresh start or “clean slate”
to the next two weeks (Dai et al., 2014). Additionally, a small task would be
encouraged related to the type of coping or problem-solving skills discussed that day.
Participants would be prompted to reflect on the class discussion and their past twoweeks’ experiences. They were encouraged to set a new food or activity goal (could be
the same as the previous week) and evaluate their confidence in achieving that goal,
identify and solve how to overcome barriers using a provided worksheet. This activity
involved the patient in their own care (Clement et al., 2018) thereby increasing
autonomy, self-efficacy, self-control and engages the participant in implementation
intentions (Bandura, 1998; Deci & Ryan, 1985).

36

3.4.2.2

Self Determination Theory. Autonomy was enhanced by offering the choice

of how to accumulate their individualized step count goal and discussing how exercise
and nutrition choices immediately effect glucose levels (rationale/explanation).
Autonomy can also be undermined by imposed goals. The aim of the step count goals
was to provide a measurable motivator and to help participants gauge their activity.
Competence was enhanced by using an adaptive goal setting approach (optimal
challenge), as it has shown to be appropriate for increasing and/or creating manageable
goals for participants (Adams et al., 2013). This was to avoid continuous increases in step
count goals unlike other ‘static’ interventions that do not consider variability in daily life
contexts/events and within person variability (Adams et al., 2013). The use of lower
number offered more opportunity to work on consistency and ability to achieve their
goal, thereby increasing competence and thus increasing levels of intrinsic motivation
(Deci and Ryan, 2000). Positive feedback regarding the previous two-weeks’ activities
was always given by the exercise specialist when sending the new prescription via email
to the participant, regardless of improvement (e.g., “You got 9/14 days of your step goal,
which is amazing! This week, with your new step count goal, think of an activity goal
that can help you try to consistently achieve this step count each day”). Relatedness can
be fostered with environments that are inclusive, respectful and caring. The intervention
included a large group component, in order to increase sharing of experiences/struggles
and strategies in a welcoming atmosphere. As well, all healthcare leaders (CDNE,
exercise specialist, physician) sought to create a positive atmosphere (e.g., finding
positive outcomes, regardless of participants’ behaviours).
3.4.2.3

Exercise Prescriptions. The daily step count goal was generated by using

whichever number was lower, either: a) the previous two-week’s daily step count mean
or b) two-week step count median. When participants’ step counts were below 10,000
steps there would be an additional 500 steps added onto the mean or median. If above
10,000 (Tudor-Locke et al., 2011), no increases were prescribed on top of the mean or
median, but rather, participants were encouraged to focus on creating goals to be
consistent around their prescribed goal. Participants were encouraged to accumulate their
step count goal through activity throughout the day and through moderate-vigorous
exercise. Participants were asked to change step count goals on their FitBit® app.

37

Participants were encouraged to interrupt their prolonged sitting with frequently (every
20 to 45 minutes, under an hour) with 2-3 minutes light-intensity physical activity
(Dunstan et al., 2012; Dempsey et al., 2016; Healy et al., 2011; Paing et al., 2019).
Strategies were discussed and provided to assist with implementation. As well, they were
encouraged to decrease overall daily sedentary time (Sigal et al., 2018). To give
participants daily feedback and reminders to get up and move every hour, participants
were advised to achieve their hourly movement goals (defined as an hour with 250 steps
or more, defined and measured by the FitBit Inspire 2™) or 2 to 3 minutes of light
physical activity.

3.5

Study Protocol

Two study protocols (i.e., ‘open’ and ‘closed’ protocols) were implemented in response
to evolving provincial COVID-19 physical distancing policies. In the ‘open’ protocol, the
technology orientation class was held in-person at the diabetes clinic (with the goal of
increasing technology uptake and ease of participation). This protocol was in place from
November 23, 2020, to December 25, 2020. On December 26th, the province of Ontario
implemented stricter physical distancing policies (“lockdown”) and so the ‘closed’
protocol was adopted, with the technology orientation class offered virtually on WebEx®
instead. After the technology orientation class, the protocols were identical. See the study
flowchart in Figure 4 below. For a more detailed protocol description, see Appendix G.
See the participant study handbook given to participants at the technology orientation
session in Appendix H.
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RECRUITMENT

Excluded:
Patient's first clinic appointment (n=116)

Excluded:

SCREENING AND CONSENT

Patient attended general 1-hour lifestyle medicine class (n=35)

STUDY PREPARATION AND BASELINE
MEASURES

Did not choose to attend general 1hour lifestyle medicine class (n=84)

Patient screened for safe exercise
(modified Physical Activity Readiness Questionnaire) (n=15)

Consent Call

Did not indicate interest (n=20)

Excluded:
Unsafe for exercise (n=1)

Excluded:

Participant provided informed consent via esignature consent while on phone or WebEx (n=14)

Did not want to participate (n=4)

Participant completed baseline questionnaires (n=10)

'Open' protocol (November 23, 2020 to December 25, 2020)

'Closed' protocol (December 26, 2020 to February, 2021)

Technology orientation class at the clinic (n=7)

Virtual technology orientation class via WebEx (n=3)

Participant picks up FitBit Inspire 2™, FreeStyle®
Libres, and study materials from clinic at the class

Participant had previously picked up FitBit Inspire 2™,
FreeStyle® Libres, and study materials from clinic

Two-week baseline step count and glucose variables collection (n=10)

Week 1 to Week 6

INTERVENTION

Drop outs (n=2)
Bi-weekly group education classes (Weeks 1, 3, 5)
Bi-weekly one-on-one check-in phone calls (Weeks 2, 4, 6)

Too busy; confident to figure out on
own
Missed two classes in a row

Week 7

FOLLOW UP

One drop out still filled out exit survey

Follow-up call (n=8)
Completed follow-up questionnaires

Figure 4. Flowchart of Protocol Timeline

3.6

Data Collection

After providing consent, participants completed four baseline surveys: (1) a sociodemographic survey (Appendix I), (2) a technology use survey (Appendix J), (3) the
Stanford Self-Efficacy Scale (Lorig et al., 2001; Ritter & Lorig, 2014) (Appendix K), and
(4) the five-item Problem Areas in Diabetes Scale (PAID-5; McGuire et al., 2010; see
Appendix L). Survey, other measurement tool, and technology equipment descriptions
can be found in Appendix M. These were completed with the help of the study researcher
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via the WebEx® platform or telephone. Baseline physiological data were extracted from
the diabetes clinic’s electronic medical records by the investigating physician (Appendix
N) and stored in REDCap. These data included sex, full date of birth, height, weight,
insulin-usage and other medications, other comorbidities, year of T2D diagnosis, and
blood pressure. One day prior to the group education classes, participants were reminded
via email to export their FitBit Inspire 2™ data from the online desktop website
(https://www.fitbit.com) and asked to share the data via a secure file transfer website,
https://filesafe.lhsc.on.ca. FitBit Inspire 2™ data was sent in order to both collect data
and update bi-weekly step count prescriptions. On the day of the class, new
individualized step count prescriptions were provided via email and participants were
instructed to replace their FreeStyle® Libres (which need replacing every two weeks). At
follow-up (week 7), participants completed the Stanford Self-Efficacy scale and PAID-5
scale over the phone with a researcher. Additionally, the participants completed an exit
survey (Appendix O) via an individualized link from REDCap.

3.7

Outcomes

To inform the development of a future pilot RCT, several feasibility outcome variables
were collected (a summary is provided in Table 2 below). First, recruitment rate was
calculated (i.e., proportion of participants providing informed consent compared to those
who attended the initial one-hour general lifestyle medicine class). The total number of
new patient intakes and number of those attending the initial one-on-one intake prior to
the one-hour general lifestyle medicine class are also reported. Retention rates were
defined as a) proportion of consenting participants completing baseline assessments, b)
proportion ‘dropping out’, and c) proportion completing follow-up assessments.
Participants missing two or more bi-weekly group education classes in a row were
considered ‘dropped out’. Intervention acceptability was assessed using exit survey
responses. Acceptability was also assessed by the mean number of patient-reported
technology issues per person. Technology issues were recorded when participants
reported a technology issue in class, on the phone, or via email. Intervention adherence
was measured in several ways, including: proportion of consenting participants attending
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bi-weekly educational classes (out of 3) and one-on-one phone call check-ins (out of 4),
number of timely FitBit Inspire 2™ data submissions (out of 3), percent of valid days
with FitBit Inspire 2™ data ([number of valid days/total days in program]/number of
participants), and the bi-weekly mean percent of ‘active time’ of the FreeStyle® Libre.
Table 2. Primary and secondary study outcomes.
Primary outcomes
• Recruitment rate
• Retention rate
• Intervention acceptability
o Mean number of technology issues/person
o Exit survey responses
• Intervention adherence
o Percent of valid days with FitBit Inspire 2™
data
o Mean ‘active time’ of FreeStyle® Libre
o On-time FitBit Inspire 2™ submissions
o Group education class and one-on-one phone
call check in attendance

Secondary outcomes
• Bi-weekly daily step counts means
• Bi-weekly daily sedentary time means
• Exercise prescription adherence
• Bi-weekly glycemic variables means
o Estimated glycated hemoglobin
(A1c)
o Time in target
o Coefficient of variation
• Self-management task self-efficacy
(Stanford Self-Efficacy Scale)
• Diabetes related-distress (PAID-5
scale)

Data was considered submitted if sent on time (within one day before or after group
education class). A valid day was defined as a day with ≥500 daily steps recorded on the
FitBit Inspire 2™ (Kooiman et al., 2018). ‘Active time’ is the mean percent of total
glucose data captured in 24-hour period every two weeks by the FreeStyle® Libre. The
FreeStyle® Libre requires at least one scan every eight hours to collect the past eight
hours of data).
Additionally, several secondary outcomes were assessed to determine whether virtual
lifestyle medicine programming holds promise and warrants further study. First, daily
step counts and total daily sedentary time were measured using the wrist worn FitBit
Inspire 2™. The FitBit Inspire 2™ was only released on September 25, 2020, and thus
has not yet been validated. An older, similar model, the FitBit Charge ™ has been
validated, however, shown to have slight overestimation in steps per day (1432 steps/day)
and underestimation in sedentary minutes (-25 minutes) in comparison to an ActiGraph
GT3X accelerometer (Mikkelsen et al., 2020). Bi-weekly daily step count means (i.e.,
steps per day) and total daily sedentary time (i.e., minutes) were collected at the end of
the baseline period, as well as weeks 2, 4, and 6. Second, exercise prescription adherence
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was measured using the equation: [(# of step count goals achieved ± SD)/(# of valid days
collected by the FitBit Inspire 2™ ± SD)]. Number of daily step goals achieved every
two weeks are also reported. Third, to assess glycemic control, bi-weekly daily ‘time in
glycemic target’ and ‘coefficient of variation’ means were examined at baseline, week 2,
4 and 6. A1c levels are traditionally collected every three months. As this was a six-week
study, A1c was measured using the bi-weekly average estimated A1c reading from the
end of baseline, week 2, 4, and 6. Finally, two diabetes-related attitudes, (a) chronic
disease self-efficacy and (b) diabetes-related emotional distress were measured using the
validated Stanford Self-Efficacy Scale and the PAID-5, respectively. These two measures
were completed at baseline and follow-up.

3.8

Data Analysis

Data analysis was performed using GraphPad Prism 9 (version 9.1.0; GraphPad Software,
San Diego, California, USA). Group data is presented descriptively, rather than completing
inferential statistics, given the feasibility nature of this study. Recruitment, retention,
acceptability, intervention adherence, and exercise prescription adherence are presented in
proportions and percentages ± standard deviation (SD). Technology issues are presented
as a mean ± SD and using categorical counts. Bi-weekly step count, sedentary time,
glycemic variables, and diabetes attitude results are presented as mean ± SD (95%
Confidence Interval [CI]). As well, descriptive participant-level data for step counts,
sedentary time and glycemic variables are provided.
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Chapter 4

4

Results

4.1

Study Sample

Ten participants were enrolled in the study (60% female, 50 ± 15 years old; range 36 to
73 years). Sample socio-demographic and health characteristics are presented in Table 3.
Mean duration of time with T2D was 2.6 ± 3.3 years. Notably, mean A1c at baseline was
under 7% (A1c = 6.2 ± 0.49 %, range 5.7 to 6.7) and mean systolic blood pressure was
over 130 mmHg (131 ± 16.7 mmHg). Due to the discovery of a misdiagnosis of Type 1
diabetes (20+ years misdiagnosis) for T2D, Participant #7’s glucose data was removed
from any glycemic measures, including baseline mean time with T2D and estimated A1c.
Half of participants self-reported household incomes below $50,000 CAD per year, and
most (70%) were not married. Baseline daily step count mean was 7103 ± 2900 (48749332. Five out of nine participants were not meeting the minimum recommended daily
step count guideline of 7000 steps per day (Tudor-Locke et al., 2011). Seventy percent of
participants self-reported being physically active for a minimum of 30 minutes per day,
three days per week. All participants had easy access to unlimited wireless Internet, and
90% reported daily smartphone use (for more information regarding participant
‘technology use’ see Appendix P).
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Table 3. Sample socio-demographic and health characteristics of participants.
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4.2
4.2.1

Primary Outcomes
Recruitment and Retention Rates. During study recruitment, the

diabetes clinic registered 136 new patients, but only 116 patients attended their initial
clinician one-one-one intake session. Of the 116, 35 patients attended the one-hour
general lifestyle medicine class. Fifteen patients expressed interest in participating in this
feasibility study, and 10 were ultimately enrolled (29% recruitment rate; Figure 1).
Reasons for non-participation (n=5) included work-time conflict, sick spouse, too busy,
did not want to wear the FreeStyle® Libre (and be identified as diabetic), or felt exercise
and nutrition were well-managed. One patient was scheduled for a coronary artery
bypass graft during the study period and was excluded. All ten participants (10/10)
completed the baseline assessments (100%). Twenty percent (2/10) of participants
dropped out of the study (i.e., Participant #1 missed two bi-weekly group education
classes in a row, Participant #8 withdrew from the study during week 5 citing too much
time and felt confidence to figure out on their own, as reasons). Eight participants
completed follow-up assessments (8/10; 80% retention rate). Of the three follow-up
assessments, one of the dropouts (Participant #8) completed the exit survey only.
4.2.2

Intervention Acceptability and Adherence. Exit survey responses

(Table 4) suggested that participants were generally satisfied with the virtual lifestyle
medicine program with 88.8% agreeing with the statement, “Overall, I was satisfied with
the program”. Participants indicated that the combined information from the FitBit
Inspire 2™ and the FreeStyle® Libre (~44%) was most helpful in learning about diabetes
management, compared to the FreeStyle® Libre (11%) or FitBit Inspire 2™ (0%) alone.
However, others indicated they felt the group-based education classes were most helpful
(~33%). Two-thirds of participants agreed or strongly agreed that their personal health
information was safe, and privacy upheld. Other responses from the exit survey can be
found in Appendix Q. Responses to the two open-ended exit survey questions regarding
study ‘likes’ (e.g., monitoring activity throughout the day, guidance on eating/exercising,
group input) and ‘dislikes’/areas for improvement (e.g., FitBit Inspire 2™ screen was too
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small, advance notice of group education class curriculum, ability to mute participants in
group) are provided in Appendix R.

Table 4. Select exit survey responses.

All participants reported at least one ‘technology issue’ (e.g., unable to access WebEx
link; 3.2 ± 2.6 issues per person). In total, 32 issues were reported, including: difficulties
sending exported FitBit Inspire 2™ data in (n=10), lost WebEx® link (n=6), FreeStyle®
Libre falling off before the two-week timepoint (n=7), submitting the wrong Fitbit® data
collection periods (n=4), problem synchronizing smartphone with the FitBit Inspire 2™
(n=3), and losing an item (e.g., the Fitbit Inspire 2™; n=2). One FitBit Inspire 2™
“malfunctioned”, where the exported FitBit® file showed step data collected, but no
sedentary minutes were provided. Most participants (~78%) said they experienced
technology issues 30% of the time or less. All participants agreed or strongly agreed that
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it was easy to join the group education classes on the WebEx® platform. Intervention
adherence was tracked using several variables. First, proportions of group education class
and one-on-one phone call check-ins attendance were 83% and 92.5%, respectively.
Participants had 93.8 ± 7.8% valid days of FitBit Inspire 2™ data during study
participation. Participants collected 78.8 ± 19.2% of total FreeStyle® Libre data (which
requires one scan every eight hours to collect eight hours of data). Participants, however,
failed to consistently submit their FitBit Inspire 2™ data within one day of the group
education classes (for exercise prescription purposes), with timely submissions only
53.3% of the time. By the end of the study, participants had sent in 98% of all FitBit
Inspire 2™ data for data analysis. All adherence data are summarized in Table 5.
Table 5. Intervention adherence.

4.3

Secondary Outcomes

Several secondary outcome variables were assessed for the purposes of demonstrating
intervention potential. On average, participants took 7103 ± 2900 (4874-9332) steps per
day at baseline and 7515 ± 3169 (4866-10164) steps per day at the end of week 6.
Regarding number of sedentary minutes per day, participants accumulated 837 ± 303
(775-899) and 975 ± 231 (925-1024) minutes per day at baseline and week 6,
respectively. Exercise prescription targets (i.e., daily step count goals) were achieved
roughly half the time (50 ± 16% of the time; 19.4 ± 6.0 daily goals met / 39.3 ± 9.3 valid
days) by all participants, and 46.6 ± 15.7% of the time by the eight study ‘completers’
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(17.5 ± 7.4 daily goals met / 36.4 ± 8.8 valid days). Individual daily step count goal
achievements can be found in Table 5. Individual mean glycemic measures (i.e.,
estimated A1c, time in target, coefficient of variation) are presented in Table 6 and group
mean glycemic measures such as biweekly estimated A1c at baseline (6.2 ± 0.49% (5.76.7)) and follow-up (6.2 ± 0.61 (5.6-6.9)), or biweekly ‘time active’ at baseline (77 ±
22% (60-94)) and follow up (77 ± 20% (59-95)) in Appendix S. Baseline and follow-up
scores for the Chronic Disease Self-Efficacy Scale (n=8) were 7.4 ± 2.0 (5.7-9.1) and 7.7
± 1.7 (6.3-9.1), respectively. PAID-5 (diabetes distress) baseline and follow up scores
(n=8) were 8.1 ± 3.3 (5.4-11) and 7.9 ± 2.7 (5.6-10), respectively.

Table 6. Bi-weekly physical activity outcome means, by participant.
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Table 7. Bi-weekly glycemic outcome means, by participant.
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Chapter 5

5

Discussion

5.1

Main Findings

This is one of the first studies to investigate the feasibility of virtually delivering a multicomponent group-based lifestyle medicine program in a population with T2D. Overall,
the protocol was generally feasible and well-accepted by participants (i.e., ~88% satisfied
with overall program with relatively low rates (<30% of the time) of technology issues).
Notably, nearly 100% of FitBit Inspire 2™ data were collected (albeit not ‘on time’), and
FreeStyle® Libre ‘active time’ approached 80% over 8 weeks (where a minimum of 70%
capture is considered ideal). Offering virtual lifestyle medicine programming with
contemporary technologies may prove possible and appears to be promising for clinical
practice. Comparisons to similar studies, protocol recommendations for future trials, and
study implications are provided next.

5.2
5.2.1

Comparisons to similar studies
Recruitment. In terms of recruitment, there was a 29% recruitment rate (10

out of 35 patients). Similar 12-week feasibility studies with different clinical populations
(i.e., adults and older adults with T2D, liver transplant patients, adults with
overweight/obesity), have reported a range of recruitment rates—from 21% to 65%
(Baillot et al., 2017; Hickman et al., 2021; Taylor et al., 2019; Zheng et al., 2020). One
six-week, three-armed pilot RCT study that included adults with high risk of developing
T2D or prediabetes recruited 77.6% of eligible participants (n=45; aged 56 ± 8.7 years;
Whelan et al., 2019). Ninety people, or 32% of potential participants were ineligible for
Whelan et al.’s study because of incompatibility between the iPhone and Libre (though
since has been resolved). In the present study, no potential participants were excluded
due to lack of sufficient technology or access to internet. As the present diabetes clinic
traditionally manages patients with lower incomes (Reichert et al., 2014), it is promising
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that there was no limiting technology or cost-related barriers to participating (though, this
may be due to selection bias).
5.2.2

Retention Rates. Of the ten who signed up, 80% of participants completed

the study. Other similar studies ranging from six weeks to six months incorporating
multiple self-monitoring technologies have demonstrated 90-100% retention rates (Jiwani
et al., 2021; Whelan et al., 2019; Zheng et al., 2020). One six-month RCT compared the
use of FreeStyle® Libre (control) (n=108; aged 47 ± 13.6 years) to the FreeStyle® Libre
plus an educational program in a sample with T2D on intensive insulin therapy (n=108,
aged 44 ± 13 years). Interestingly, the control group retained 96.4% participants (5/108)
and the intervention group a lower rate, at 88.9% (96/108) (all lost to follow-up).
Examining the reasons for dropouts in the present study (i.e., time commitment, viewed
as not valuable, loss to follow-up), it seems unlikely that the virtual delivery would have
been the mediating factor for withdrawal like in previous studies (Dasgupta et al., 2017;
Tomlinson et al., 2020).
5.2.3

Acceptability. Acceptability was measured by number of technology issues

per person and participant exit survey responses. Overall, the findings of this study
suggest the protocol and methodology to be acceptable. There were a low mean number
of technology issues per person (3.2 ± 2.6 issues per person). Whelan et al. (2019)
reported a total of 262 FreeStyle® Libre replacements were supplied to participants
(n=45), due to misplacements or faulty sensors during their six-week intervention.
Replacing 262 sensors over a very short period is costly, thus proper placement and
prevention education should be identified. The present study only reported seven
FreeStyle® Libres falling off prematurely, and usually occurred within three days or less
of sensor replacement. In terms of using the videoconferencing platform, there were no
reported issues with hearing or lag issues with the video group educational classes in this
study, which is encouraging for future virtual delivery. In contrast, other
videoconferencing lifestyle medicine program group education classes have reported
audio/video lags or drops in calls 20-25% of the time or reported Internet instability
issues (Cliffe et al., 2021; Hickman et al., 2021; Tomlinson et al., 2020). Exit survey
responses shed light on some aspects of intervention acceptability, such as opinions about
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the FitBit Inspire 2™ and FreeStyle® Libre usefulness and group classes experiences.
Almost half of participants (44%) reported the combined biofeedback from the FitBit
Inspire 2™ and FreeStyle® Libre was the most helpful in learning how to best manage
their diabetes. Interestingly, 35% of participants felt the FreeStyle® Libre was most
motivating in increasing physical activity, followed by the group education classes (25%)
and FitBit Inspire 2™ (25%). This could indicate that there may be value in combining
FGM and wearables for learning (Gonzalez et al., 2016; Liao et al., 2020) and treatment
satisfaction (Gal et al., 2020; Hermanns et al., 2019; Wada et al., 2020). As well, multicomponent interventions could be more likely to satisfy multiple individuals’ needs with
a wider range of accessible resources. Most participants on the exit survey agreed or
strongly agreed (67%) that “the option to use the FitBit Inspire 2™ was a great
motivational tool”. These responses are in line with participants experiences from
previous studies using a FitBit® (Jiwani et al., 2021; Kooiman et al., 2018; Maher et al.,
2017).
5.2.4

Intervention Adherence. Group and phone call check-ins had averaged

mean attendance rates of 83% and 93%, respectively. A 12-month non-randomized trial
comparing the video delivery of (a) one-on-one counselling sessions with an
endocrinologist (every three months) (n=33; 56.7 ± 9.4 years) and (b) group DSME with
a certified diabetes educator (every three months for two hours) (n=36; 56.5 ± 6.7 years)
in rural community patients with advanced T2D provides context for the present findings
(Nyenwe et al., 2020). At least 40% of participants in each group missed at least one
appointment. Sub-analyses revealed those who attended less than 50% of classes were
more likely to be younger, which is similar to previous evidence (Adams et al., 2013;
Kirkman et al., 2015) and what the present study suggests as well. Other attendance rates
of virtual lifestyle medicine programs using videoconferencing to deliver classes have
widely ranged from 52-95% (Baillot et al., 2017; Hickman et al., 2021).
In the present study, data presented with and without dropout participant data displayed a
94% rate of valid days of FitBit Inspire 2™ data over the course of the study. One threemonth lifestyle program combining multiple self-tracking technologies in an older adult
sample with T2D, reported 85.2 ± 19.7% valid days of FitBit® data (Zheng et al., 2020),
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whereas Whelan et al. (2019) reported 95% of valid days of data were collected during
their six-week feasibility study.
Four participants had their lowest ‘active time’ of FreeStyle® Libre (the total percent of
data captured) in study weeks five and six, which could potentially indicate the start of an
often-cited phenomenon in digital health intervention referred to as “non-usage attrition”,
as previously described (Eysenbach, 2005). However, group means of ‘active time’
hovered at 77% at both baseline and follow-up. In contrast, Whelan and colleagues
(2019) noted a continuously decreasing ‘active time’ of the FreeStyle® Libre, having
87.6% in the first week and dropping to 82% by the sixth week. Zheng et al. (2020) (who
utilized multiple health monitors including a FitBit® and a nutrition tracking app) noted
consistent high engagement levels with their technologies up until week 6 and then
noticed a trending decline for the next six weeks. Given the small sample of this study,
this non-usage attrition claim is speculative. Regardless, since non-usage attrition is
common in this context (Eysenbach, 2005) strategies for preventing or minimizing it
should be considered moving forward (e.g., eliminating user ‘friction’, drawing to new
program features as time passes, etc.), as higher engagement (scans) with the Libre®
FreeStyle is associated with better A1c (a future primary outcome) and decreased time in
hypo- and hyperglycemia (Dunn et al., 2018).
5.2.5

Physical Activity Outcomes. Overall, there does not appear to be any

trends when examining group mean daily step counts from baseline to follow-up. Some
participants’ individual bi-weekly mean step counts trended upwards, and some down.
Individual daily step goal achievement also varied, though group means number of daily
step count goals achieved were trending upward over time (which could suggest
increased daily step count consistency). Individuals with downward step count trends
may have been subject to the ‘Hawthorne Effect’ (when people behave differently when
they know they are being watched/monitored; Landsberger, 1957), either during the
baseline period or the initial two intervention weeks. However, it is also possible that
Ontario’s COVID-19 pandemic transition from partial to full lockdown restrictions
during the study (on December 26th, 2020) left some people with either decreased
opportunity or motivation to continue to be active. Additionally, this study was conducted
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during the winter in Canada; winter seasons have previously shown decreased steps
compared to warmer seasons (Clemes et al., 2011). In contrast to the current step count
data, one 12-week self-monitoring eHealth intervention utilizing FitBit® monitors
reported significant increases in steps per day (a mean increase 1255 ± 1500 steps per
day; (p<0.01) from baseline (5978 ± 2982 steps per day) (Kooiman et al., 2018). Metaanalyses have reported increases of 2000 or more steps per day over periods of 6 to 12
months (Dasgupta et al., 2017; Qiu et al., 2014; Vaes et al., 2013)). Nonetheless, this
study was not powered to determine statistically significant changes, nor primarily
targeted change in daily step counts as the goal was to assess the feasibility of using steps
for bi-weekly exercise prescriptions and data collection.
Participant baseline mean daily sedentary behaviour time was roughly 14-15 hours per
day. In contrast, current evidence suggests that in the general population, the average
Canadian adult aged ≥ 35 years accumulates about 9.5 to 10 hours per day (Prince et al.,
2020). Sedentary time may have also trended upwards over the course of the intervention,
though this study was not powered to draw firm conclusions in this regard (baseline
period: 837 ± 303 (775-899) minutes per day; weeks 5-6: 975 ± 231 (925-1024) minutes
per day). Given that these data were either collected with some COVID-19 restrictions or
under total “lockdown”, these higher (and potentially rising) levels seem to be matching
up with claims of predicted increases in sedentary behaviour during the COVID-19
pandemic (Marçal et al., 2020). Regardless, this is particularly concerning as higher and
longer periods of sedentary behaviour are strongly linked to increased risks of insulin
resistance, heart attacks, Alzheimer’s/ dementia, and all-cause mortality (Dempsey et al.,
2016; Dunstan et al., 2012; Healy et al., 2008; Loh et al., 2020). This type of behaviour
should at minimum be targeted more heavily and emphasized more to this population,
especially as targeting sedentary behaviour can be a great method to ease people into
increasing physical activity (Colberg et al., 2016; Dempsey et al., 2016) and has shown
decreases in A1c and weight (Dempsey et al., 2016; Dunstan et al., 2012; Healy et al.,
2008; Loh et al., 2020).
5.2.6

Diabetes Related Attitudes. Breaking down the specific categories in

the Stanford Self-Efficacy Scale suggest levels of emotional distress may have decreased
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during the study, though again, firm conclusions must not be drawn (8.4 to 7.75, range 110). As well, general self-efficacy scores demonstrated a small increase, and particularly
the lower end of the 95% confidence interval (7.4 ± 2.0 (5.7-9.1) to 7.7 ± 1.7 (6.3-9.1).
This may indicate that those with lower self-efficacy may have benefitted more, as well
as the intervention having influence on competence levels, though a larger study is
needed to confirm these claims. In the PAID-5 scale, participants appear to have reported
lower levels of “feeling scared when thinking about living with diabetes” and “worrying
about the future and the possibility of serious complications”. This downward trend
indicates potential acceptability of our intervention as well, as participants may feel more
confident and knowledgeable as a result of the intervention and thus have fewer concerns
and/or fears. Interestingly, “feeling that diabetes is taking up too much of your mental
and physical energy every day” scores may have increased for some. Theoretically, it is
possible that if participants had not previously been engaging in self-management
practices and had increased involvement, both the learning curve and added effort may
have increased mental strain. Other virtual interventions using CGMs or FGMs have
reported no significant changes in psychological well-being, depression score,
empowerment, self-efficacy, hypoglycemia worry (Hermanns et al., 2019), or perceived
stress (Taylor et al., 2019), yet some have reported significant decreases in management
distress, emotional burden and behavioural burden (Gal et al., 2020; Hermanns et al.,
2019).

5.3
5.3.1

Protocol Refinements
Recruitment and Sample Characteristics. Several opportunities

were identified to improve the study protocol, and the intervention specifically (Table 8).
First, the number of people recruited compared to the number of new patient intakes that
were seen during the recruitment period (10 vs. 116) was relatively low. Postrecruitment, a lack of clinical referrals to the general lifestyle medicine class was
identified as one possible explanation. This could be addressed in part by giving clearer
instructions to clinicians in the future. Second, T2D appeared to be generally wellcontrolled in the current sample with baseline estimated A1c of 6.2% (below the typical
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7% target for most adults), which limits the generalizability of these results (Pillay et al.,
2015). If a similarly well-controlled sample were to be recruited in a future study, this
could impact results (i.e., limited room for improvement; Pantalone et al., 2020; Wada et
al., 2020). Additionally, both insulin and non-insulin users were included in the current
Table 8. Key intervention and protocol refinement recommendations.
Description of
Study

Current Protocol

Optimization for Future Studies

Recruitment

Low referrals to the one-hour
general lifestyle medicine class by
clinicians from diabetes clinic.
Well controlled diabetes (baseline
estimated A1c = 6.2%). Both insulin
and non-insulin users included.

Clearer instructions for clinicians.

Sample

Technology

Group Class
Dynamics

1.

2.
1.

2.
3.

Multiple issues with study data
submissions due to a relatively
complex protocol (i.e.,
downloading a FitBit™ excel
file from desktop/laptop and
uploading to a secure file
sharing website).
Sound feedback issues.
Low participant participation in
group discussions, led to more
didactic class format.
Difficulty “reading the room”
when phoning onto the call.
Rolling intake format

Exercise
Prescription
and Physical
Activity
Outcomes

Step count prescriptions only.
Participants provided choice on
“how” to accumulate the steps (with
advice from exercise specialist).

FreeStyle®
Libre

Potential decrease in engagement
with FreeStyle® Libre

A1c = glycated hemoglobin

Consideration of type of sample; controlling
for important diabetes related sample
covariates (i.e., medications, insulin, baseline
A1c. Sub-analysis of insulin users vs. noninsulin users.
1. Providing option to email/text in
screenshot of two-week FitBit® step
count summary or implement automatic
data upload to server.
2. Ensure class facilitator mute capabilities.

1. a. Provide one-page content summaries
to review prior to class for content
familiarization (increase ease of discussion);
provide small homework assignments to reenforce learning and encourage more
meaningful conversations.
b. Emphasize the importance of sharing
and peer learning
2. Ensure participants are participating via
the video platform (camera on or off).
3. Remove rolling intake, have set start and
end dates for programs.
1. Offer participants choice of type and
frequency of a preferred exercise (to
supplement or replace step count goal); offer
specific prescriptions for minutes of walking
(to help achieve step count goal); increase
frequency and automation of personalized
feedback.
2.
Consider tracking change in physical
activity intensities levels using research-grade
accelerometer.
Create short booster sessions with specific
topics, to encourage further exploration of
personal data and shared experiences.
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sample. Current evidence and clinical practice support the use of CGM in insulin users
(Beck et al., 2017; Haak et al., 2017; Yaron et al., 2019); yet, the efficacy, let alone the
practical, cost-effective use of the CGM or FGM in non-insulin users remains
controversial due to limited supportive evidence (Allen et al., 2008; Diabetes Canada,
2020a, 2020b; Lipscombe et al., 2018; Robertson et al., 2020; Wada et al., 2020).
According to some, non-insulin users should be provided an opportunity for earlier
lifestyle choice adaptations (reducing the potential need to use insulin), in addition to
increasing the evidence on efficacy of FGMs in this population (Wada et al., 2020).
Inclusion of sample characteristics such as degree of glycemic control and/or insulin
usage should be considered in the design of future trials (e.g., block randomized control
design, include as co-variates in analyses, etc.; Balducci et al., 2019), especially when
using FGMs (Pantalone et al., 2020).
5.3.2

Technology Issues. There were relatively low mean numbers of reported

technology issues per person, and most were related to study-related data submissions (14
total). Data submission issues may have been related to the complex study
protocol/procedures, which had to follow ethics-mandated secure data transfer and
involved the inclusion of FitBit® Excel file for data collection (and was complex for
some participants). This complex protocol also may have resulted in suboptimal
Fitbit/Libre submission rates (~53%). This matter was addressed early in the study by
providing the option to send in a smartphone screenshot of the two-week FitBit® app
summary as an alternative option. Moving forward, this is a critical issue that needs to be
addressed to increase clinical practicality and reduce participant burden (such as
automatic data upload to a server for clinician viewing; e.g., Kato et al., 2020) or at
minimum, data submission via email (Michaud et al., 2021). Overall, it was valuable to
have a technology support person on hand to resolve issues quickly, as has been
previously recommended (Aberer et al., 2021).
5.3.3

Group Class Dynamics. Exit survey feedback identified several areas for

protocol refinement as well. For example, there were varying responses about
participant’s level of comfort speaking during the group education classes. Virtual group
environments via video can prove to be difficult for members to assess body language
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and feel others’ emotions, in addition to leaving plenty of opportunity for
miscommunication and negative experiences (Parks, 2020). The original protocol
planned for semi-structured classes, that were primarily non-didactic (led by participants)
to increase relatedness and peer learning. This proved to be challenging as many openended questions (e.g., “what type of physical activity goal do you want to set for the next
two weeks?”) did not stimulate as much discussion as intended. Perhaps this could be
attributed to (a) not being able to ‘read the room’/participants being shy or not
comfortable speaking in public, (b) not wanting to disclose health goals due to feelings of
embarrassment or vulnerability, or (c) low familiarity with the education topic. For
example, exit survey responses revealed requests for advance review of group education
class material, so that they could be familiar with the topic and easily engage in
discussion. Although the slideshow files were sent one day in advance, either participants
did not look at them beforehand or the slides may have been too dense or long to review.
In the future, a course package that includes comprehensive questions to solidify the
previous class discussion, as well as content (e.g., one page summary) for the next class
could be provided. Issues with sound feedback during group calls were identified. This
was exacerbated when one of the participants was calling in by the phone. In the future,
having facilitator muting capabilities is highly advised to ensure a better experience for
everyone (Connor, 2018). As well, whenever possible, encourage participants to attend
the video call (even if the individual has their video off) to be able to see others and “read
the room” better is recommended, in order to increase group cohesion (Connor, 2018).
Other recommendations to increase group cohesion are to avoid rolling in-takes.
5.3.4

Physical Activity Data Collection. Additionally, although only daily

step count data was collected for this study, Fitbit® monitors are capable of tracking
minutes of physical activity at different intensities (though additional data is required to
do so, including participant weight/height). Measuring levels of physical activity
intensities (e.g., moderate to vigorous intensities) may provide additional insight on
change in exercise behaviours in the future (O'Brien et al., 2018).
5.3.5

Self Determination Theory. The self-determination theory can be used

to target health behaviour change (Halvari et al., 2017; McSharry et al., 2020; Shigaki et
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al., 2010), and a stronger application in the current context may yield better results (e.g.,
better attendance, larger daily step count increases, greater reductions in A1c). Although
the intervention sought to target the three psychological needs and in doing so increase
intrinsic motivation, these psychological outcomes were not measured. For future studies,
a fidelity check to ensure the intervention is appropriately targeting the three needs and
shifting motivation intrinsically is needed. The Behavioural Regulation in Exercise
Questionnaire (BREQ-3), for example, is used to assess types of motivations for exercise
on the motivation continuum and is recommended for future studies (Markland & Tobin,
2004; Wilson et al., 2006). The use of step count prescriptions to elicit change in daily
step counts were perhaps not sufficient. It is possible that participants: (a) did not want a
step count goal only but needed a more specific exercise prescription that included type,
time, and/or intensity of aerobic exercise, (b) did not fully comprehend how to
accumulate steps through exercise, or (c) were simply not motivated by a daily step count
goal. Step count goals may have imposed an unwanted goal, which have shown to
decrease intrinsic motivation (Ryan & Deci, 2000b). To increase autonomy, future
studies should consider offering participants the choice of type and frequency of a
preferred exercise, for instance, to supplement the step count goal, or to fully replace the
step count goal (Halvari et al., 2017). As well, offering participants the option to receive
recommended prescriptions for minutes of walking (to help achieve step count goal) may
also increase levels of autonomy. Lastly, providing increased levels of positive
performance via automated personalized feedback (e.g., automated SMS texts; Hochberg
et al., 2016) may increase levels of competence (Ryan & Deci, 2000a). To increase
competence levels further, the FreeStyle® Libre should be leveraged more heavily to
increase feelings of knowledge and control over diabetes progression. Participants found
the FreeStyle® Libre to be the most helpful with increasing physical activity (37.5%) and
helped guide food (100%), physical activity (~78%), and medication (~33%) decisions.
To further leverage and stimulate (or at least maintain) individual engagement with the
FreeStyle Libre sensor, short group “booster” topic-specific, guided sessions could be
beneficial; thereby, not only learning interpretation basics, but having participants
interact with, and share their data as a group (fostering both competence and relatedness).
Lastly, a stronger application of self-determination theory may lead to even greater
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increases in feelings of social relatedness. As mentioned, group discussions proved
difficult to facilitate, for several reasons. For the third group-education class, a fun group
icebreaker was implemented. These appeared to be well received and may have promoted
participant engagement during the session, however no data were collected to quantify
this statement. Creating questions in advance to prompt discussion to compliment lesson
material (e.g., “Does anyone feel scared to exercise?”) or having assignments to prepare
and feel comfortable to engage for more in-depth group discussions (e.g., preparing to
share glucose trends after eating something that made their glucose spike, or exercise
etc.) could be used. This could help increase group cohesion to foster better conversations
that may lead to increased opportunity for peer learning, motivation (e.g., “If they can do
it, I can do it”; Jiwani et al., 2021)), and feelings of competence and relatedness. In order
to support increase group cohesion, other strategies can include adding in a group name
(group environment distinctiveness), group collective goals (e.g., collaboratively creating
a group goal to attain X amount of distance during the program), or increasing group
problem solving activities (Estabrooks et al., 2008; 2012)
In summary, refinement to the data submission protocol to decrease barriers (i.e., time,
frustration, effort), offer exercise choice and increase performance feedback frequency,
implement small engagement FreeStyle® Libre boosters, and increase group engagement,
may prove to be useful in intervention adherence and engagement, and possible longterm study retention.

5.4

Strengths and Limitations

This study was novel, as it is one of the first studies to evaluate the implementation of a
multi-component virtual group lifestyle medicine program for adults with T2D. A large
strength of this study was the strong alignment with the ORBIT model (Czajkowski et al.,
2015). Many of the participants were of lower incomes, which can further support the
feasibility of this type of program (as technology ownership could have been a limiting
factor). As well, this study was very successful in collecting all study related data
virtually (~100% of FitBit data, 79% of FreeStyle® Libre data). Lastly, this study was
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positioned to capitalize on the COVID-19 pandemic, as we were able to test this setting
in a “real world” clinical setting, ultimately adding to the ecological validity of this study.
However, this study has limitations that must be considered when interpreting the results.
First, baseline data was extracted from the most recent records available on the electronic
medical record. Therefore, not all baseline physiological data measurements were
completed at the same time relatively to the study start date, and some data were missing.
Second, this study had a small sample and was conducted over short period of time (six
weeks). These issues were due, in part, to COVID-19 related physical distancing policies
that delayed project initiation. However, other studies testing the virtual delivery of
lifestyle medicine programs report similar sample sizes (Baillot et al., 2017; Burkow et
al., 2018; Tomlinson et al., 2020; Zheng et al., 2020). Second, while health behaviour
change interventions in this field are typically 12-weeks or longer (Kooiman et al., 2018;
Peacock et al., 2020; Umpierre et al., 2011; Yang et al., 2020; Zheng et al., 2020) this
current study was only six weeks in duration. A longer study may have yielded different
results. Third, this was an uncontrolled, single group cohort study. More engaged, healthy
diabetes clinic patients may have volunteered to participate in this study (‘self-selection
bias’) as is often reported in similar studies. The characteristics of this small, potentially
more engaged/healthy sample may have affected the feasibility outcomes reported here.
(Mardanian Dehkordi & Abdoli, 2017). Fourth, despite individualized exercise
prescription playing an important intervention role, cardiorespiratory fitness (a key
cardiovascular disease risk factor) was not assessed. Moving forward, utilizing validated
tests such as the six-minute walk test or a step test should be considered (Hansen et al.,
2013; Lee, 2018). Fifth, a daily step count of 500 steps or more was a considered a full
day worth of data (‘valid day’; Kooiman et al., 2018). Looking ahead, an updated
definition of ‘valid day’ may include the time between the first and last daily step
recorded, with the valid days counted if at least 8-10 hours between first/last count (either
via self-report or heart rate data). As well, previous evidence suggests wrist-worn
accelerometers can inflate step counts compared to hip-worn monitors (Mandigout et al.,
2019). Thus, FitBit®-related data should be interpreted with caution. Sixth, this study
was non-blinded. The research trainee/author collecting and analyzing data was also the
exercise specialist, which may introduce observer bias to data interpretation (Mahtani et
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al., 2018). Lastly, the mostly discrete response format of the exit survey could only
provide so much insight (vs. for example, focus groups; e.g., Jiwani et al., 2021, ORBIT
Phase I recommendations, Czajkowski et al., 2015). Important participant
insight/feedback may not have been captured.

5.5

Implications and Future Directions

This study is one of the first studies to deliver an almost completely virtual lifestyle
medicine program in a group setting while simultaneously utilizing FGMs, wearable
activity monitors, and individualized exercise prescriptions. In general, this intervention
package (if shown to be efficacious in future studies) may address a number of low
DSME attendance barriers, increase program accessibility, and better equip people living
with T2D to self-manage their chronic condition (Sim & Lee, 2021). This study suggests
that a virtual lifestyle medicine program can be feasibly delivered in a clinical, real-world
setting, even amidst a global pandemic. Multiple participants were reached at once,
which required less clinician time/resource and provided the opportunity for peer learning
and increased feelings of social relatedness (not otherwise possible in one-one-one virtual
appointments). One consideration of this program is its institution-level feasibility.
Although not assessed in this study, future work should evaluate time usage of staffing
(i.e., reception, healthcare practitioners) and resources such as wearables or technology
platforms, spent in running the program. However, an end goal of a this type of program
is to have a fully developed program that no longer needs fine-tuning and thus requires
significantly less work. Providing FreeStyle® Libres free-of-charge and/or loaning FitBit
Inspire 2™ monitors may be costly, and begs the question, ‘should clinics be investing in
expensive health technologies to support self-management?’. Although these costly tools
may likely prove to be more efficacious in a high-risk, high-cost populations, researchers
and clinicians should consider whether to indeed promote relatively high-cost health
technologies in lower-risk patient groups (e.g., non-insulin dependent). In real-world
settings, not everyone will have access or can afford to use FGMs, as they are only
covered in some Canadian provincial healthcare systems, and in some instances only by
insurance companies if the person is using insulin (Diabetes Canada, 2020a, 2020b). As
well, not everyone is going to own or be able to afford a FitBit® (or other wearable
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activity monitor; Patel et al., 2015), nor continue to wear them long term. One consumer
report revealed that half of an adult sample (n=6223) claimed they stopped using their
wearable, and one third of these stopped within six months of owning one (Maddox,
2014). Therefore, programs should also consider leveraging smartphones as a cheaper (or
second choice) alternative as they have demonstrated reasonable accuracy as a daily step
count monitoring tool (if worn on their person, e.g., in pant pocket; Bonn et al., 2018;
Patel et al., 2015; Sullivan & Lachman, 2016). Finally, it must be acknowledged that
virtual participants in DSME might not be for everyone. Offering these types of virtual
options should likely be done to compliment rather than replace existing services
(Maddison et al., 2019).
Aligning with Phase Ib of the ORBIT model (Czajkowski et al., 2015), the protocol was
adapted as needed. Any changes needed were mostly related to optimizing delivery and
content for classes. This study exhibited a successful adaptation of the lifestyle medicine
program (including a new mode of delivery) previously delivered at the diabetes clinic
(Phase Ib). Moving forward, with increased confidence in the intervention package
discussed and refined here, the next step is to move onto a proof-of-concept test (IIa) or a
pilot feasibility trial (IIb) to determining if clinical significance is possible and further
refine the protocol if necessary. A fixed treatment protocol outline and creation of an
intervention delivery manual are necessary for rigorous and quality delivery. A small,
specific sample should be chosen using criteria previously discussed, prior to a larger
more generalizable sample in Phase III. Testing the efficacy of virtual delivery against inperson delivery in a primary clinical endpoint, such as A1c (Phase IIb), prior to moving
to final the Phase III efficacy trial is recommended.

5.6

Conclusion

The results of this study show that it is feasible to conduct a study that delivers a virtual
group-based lifestyle medicine program that uses wearables and individualized exercise
prescriptions. However, several refinements to the protocol are needed prior to moving
forward to a pilot trial (e.g., better data transfer, increased options for exercise
prescriptions, etc.). Future research is warranted to determine the efficacy of this style of
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delivery modality and multi-component intervention in improving physical activity and
glycemic control outcomes.
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Appendix B
Recruitment
Routinely, after their initial intake, all new patients at the diabetes clinic are to be referred
by their healthcare practitioner to a one-hour general lifestyle medicine class. From
November 2020 to late December 2020, Ontario was under COVID-19 yellow and red
restrictions (ten and five people indoor gatherings, respectively), during which the diabetes
clinic held these lifestyle medicine classes in person (while also offering simultaneous
online attendance as an option as well). As of December 26th, 2020, Ontario entered a
complete COVID-19 lockdown (grey restriction; no group meetings) and the classes
moved entirely virtual. All virtual classes were held using the WebEx® video platform.
As such, participating patients had to have access to technology (in line with technology
inclusion criteria) that enabled WebEx® participation. At the end of the one-hour general
lifestyle medicine class, patients were invited to participate in the study.
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Appendix C
Letter of Information and Consent: Open Protocol
Study Title:

Virtually Delivered Lifestyle Program Integrating
Wearable Technology and Exercise Prescriptions in
Patients with Type 2 Diabetes (STAND-VAT): A
Feasibility Study

Principal Investigator:

Sonja M. Reichert, MD MSc CCFP. Assistant Professor,
Department of Family Medicine, Western University.

1. Introduction and Invitation to Participate
As you have type 2 diabetes and participated in the one-hour Lifestyle is Medicine
education class you are being invited to participate in our research study.
2. Purpose of the Letter
The purpose of this letter is to provide you with the information that is required for you to
make an informed decision about participating in our study. We invite you to read this
letter closely.
3. Background and Purpose of this Study
The St. Joseph’s Primary Care Diabetes Support Program (PCDSP) has offered an inclinic group program called STAND for people interested in learning more about exercise
and nutrition as one type of treatment for type 2 diabetes for the last few years.
Due to COVID-19 restrictions, the program will now be delivered virtually starting in
September. Virtual care delivery (i.e., video healthcare appointments) is becoming more
common and can decrease travel time and other hassles. Additionally, wearable
technology (e.g., FitBits) are now often used in remote healthcare monitoring. However,
we do not know if it is feasible to incorporate supervised exercise programming and
wearable activity monitors into the clinic’s STAND program.
We will offer you the use of activity monitors (a FitBit). We also hope to understand if
we can coach you virtually to use this wearable technology and if it affects your
confidence in your diabetes management and exercise behaviours. You are being asked to
participate because the information collected from your experiences and responses in this
study will help us decide if virtual delivery of the STAND program is something we can
offer again in the future, and if so, how to improve it.
4. Study Design and Procedures:
If you choose to participate in this study, you will need to first be eligible and medically
cleared by a PCDSP nurse practitioner or doctor before participating in this study. The
total time you will be involved with the study will be a one-week preparation, two-week
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baseline, six-week intervention, and one follow up week immediately after the
intervention finishes. The follow up testing and questionnaires will occur one week after
the six weeks of the intervention.
During the intervention, you will be required to attend the program’s virtual 1-hour group
classes every two weeks (at a prearranged time). The following is a description of
additional features of the study (on top of the normal diet/exercise counseling (which
includes wearable glucose monitors, FreeStyle Libre sensors (Abbott)) you would usually
receive for six weeks through the regular STAND program at the PCDSP if you chose
not to participate in this study).
To begin, the clinic will have already provided you this Letter of Information and four
short surveys to review. A study investigator will video call you to review any questions
you have, then you will confirm your consent to participate via REDCap. REDCap is a
secure, online data collection platform; you will be send the link via email to access the
consent page. On the same call (if you agree to participate), you will answer the survey
questions the Master’s student.
The day of your in-person orientation class, you will receive your FitBit along with any
other STAND related items, including your FreeStyle Libre. During the class, one of the
researchers and clinic staff will teach you how to set-up and use your FitBit, along with
other parts of the normal STAND program. You will wear the FitBit and your FreeStyle
Libre every day after this orientation class until the program completes. Two weeks after
the orientation class, you will attend your first virtual STAND-VAT class. At the first
class you will receive your first personalized step count goal. This program will be
individually adjusted every two weeks.
You will be asked to send in your FitBit data and FreeStyle Libre glucose numbers to the
clinic the day before each group class you attend (on Sunday). A PCDSP practitioner will
review your glucose data, and the exercise specialist apart of this study (MH) will review
your FitBit data. This information may be discussed during the 1-hour virtual STAND
group session if you volunteer to do so and will be used to create a new bi-weekly
personalized step count goal by the exercise specialist. Within one day of the class, you
will receive a summary email about your new step goal.
For the six weeks of the intervention, one week after each class, you will be briefly
contacted by telephone by the exercise specialist (MH) (these calls will end after 6
weeks). This call is to discuss how your exercise is going, confirm your exercising is
safe, and if you have any technology or study questions. One week after sixth week of
the intervention, you will answer two of the surveys you completed before the program
started and an exit survey. The exit survey will ask you about your study experience and
for any suggestions for improvement. These surveys will be done on a one-on-one video
call with the Master’s student. You will be required to return your FitBit to the clinic
after the program finishes.
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5. Voluntary Participation:
Your participation in this study is voluntary. You may decide not to be in this study, or to
be in the study now and then change your mind later. You also may choose to skip any
survey questions that you do not wish to answer, by saying, “pass”. You may leave the
study at any time without affecting your care. We will give you any new information that
is learned during the study that might affect your decision to stay in the study.
Additionally, sharing exercise or glucose data with the rest of the class for learning
purposes is completely voluntary. You may refuse to share data with the rest of the class
without any consequence to your care and will be followed up with a Certified Diabetes
Nurse Educator to make sure you understand your own data.
6. Withdrawal from the Study:
If you decide to withdraw from the study, the information that was collected during the
study can be removed upon request. No new information will be collected without your
permission. You reserve the right to delete your FitBit account if you wish. You, solely,
hold your own access to your FitBit account.
7. Benefits:
You may not directly benefit from being in this study. However, you may benefit from
this study in a few ways:
a) You will have the opportunity to self-monitor your current physical activity levels by
using the FitBit.
b) You will receive personalized exercise programming with support from a coach and
other peers to work towards your exercise goals.
Overall, the information learned from this study may be used to lead improved diabetes
management strategies in the future, which can benefit other people with diabetes too.
8. Risks, Harms, or Inconveniences:
Expected risks or discomforts related with participating in this study include disruption of
your personal time to complete the required needs of the study. We do not expect any
severe risks, harms, or inconveniences, however there are a few you need to be aware of:
a) Inconveniences: You will need to send in FitBit data every two weeks. You will also
be contacted every other week (on weeks without classes) by a researcher to discuss
your exercise routine and technology experiences. You may experience technical
difficulties (i.e. struggling to figure out your FitBit or how to send your data in),
which may increase frustration and/or result in requiring more time than you
anticipate. Please note that a clinic IT person or the Master’s Kinesiology student will
be available to assist you if you need help.
b) Privacy: There is always a possibility for privacy breaches. We have taken
precautions using encrypted, password protected files and a research-grade data
storage server. Our video calling platform is secure and uses encryption software.
Like online shopping, teleconferencing/videoconferencing technology has some
privacy and security risks. It is possible that information could be intercepted by
unauthorized people (hacked) or otherwise shared by accident. This risk cannot be
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completely eliminated. It is recommended that you use your home computer or
personal device, and not a shared or work device to ensure privacy. For your FitBit
account, we will put your email address, birth year, sex, and height/weight in order to
get accurate feedback for us and you. Below, you will be asked to review and sign the
Patient Acknowledgment and Consent Form FitBit® Activity Program.
c) FitBit Data: FitBit data shared with the study investigators will be used using the St.
Joseph’s Health Care (SJHC)’s secure patient file sharing platform. We will also ask
for your email address, as it will be necessary to communicate with you occasionally
using email i.e. to send you study questionnaires and study information. Please be
aware that email is not a secure or confidential form of communication. As the
message leaves SJHC, it is sent across the Internet, where it could be intercepted and
read. For this reason, SJHC cannot guarantee the security of messages that are sent to
and by us. We will not use email to communicate sensitive personal or health
information. Email will NOT be used to communicate emergency or urgent health
matters.
d) Negative feelings: As changing your lifestyle habits can be very hard, especially on
top of daily self-management practices, the study has the potential to:
a. cause feelings of distress or frustration (e.g., stress from learning to use new
technology), or
b. decrease confidence or feelings of disappointment about lifestyle changes
(e.g., you finding you are not achieving your goals like you wanted). We will
work with you to make your goals achievable. One of the researchers or
exercise leader can always be reached if you are having difficulties with your
prescription.
e) Safety: As with any exercise, you may be at risk for mild soreness (if you have not
exercised in a while), developing a foot blister, and even hypoglycemia if you are
taking medication that can cause hypoglycemia. Before starting the program, you will
be medically cleared to ensure high levels of safety while participating in this study.
We will also teach you how to exercise safely as a person with Type 2 Diabetes.
9. Confidentiality:
Special care will be given to protect your confidentiality. Identifying information (phone
number, email address, names and date of birth), will be kept separate from our main
study data and will be stored on a password protected, secure, research grade platform
(REDCap). All other electronic study documents will be labeled with only your study
number and will be encrypted, and password protected on the Western OneDrive; this
data will be wiped after the study completes. All study-related information will be kept
for 15 years after the study has been completed. Representatives of Western’s Research
Ethics Board and the Lawson Quality Assurance and Education Program may contact you
or may access your study-related records to monitor the conduct of the research.
The information from this research project will be submitted, when the study ends, for
publication in a peer-reviewed academic journal as well as presented at related
conferences. You will not be named in any report, publication or presentation resulting
from this study.
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10. Costs:
You will not have to pay to participate in this study.
11. Rights as a Participant:
You do not waive any legal right by signing this consent form
12. Conflict of Interest:
Some of the clinicians are our study investigators. Thus, the doctor or nurse practitioner
treating you may also be the practitioners in charge of this study. Participating in this
study, however, will in no way jeopardize your care at PCDSP.
13. Questions About the Study:
If you have any questions regarding your participation in the study, please contact one of
our co-investigators, Elizabeth Harvey (RNEC, MScN CNS/ Nurse Practitioner) at or Dr.
Sonja Reichert (Co-Principal Investigator); or Dr. Marc Mitchell (Co-Principal
Investigator) or Madison Hiemstra (Master’s Student at Western University).
If you have any questions about your rights as a research participant or the conduct of this
study, you may contact SJHC Patient Relations Phone at 519 646-6100, ext. 61234;
email: patientrelations@sjhc.london.on.ca.
Patient Acknowledgment and Consent Form: FitBit® Activity Program
As part of my care at the Primary Care Diabetes Support Program, I understand that I
may choose to participate in a fitness program/evaluation whereby I will wear a FitBit
Inspire HR and share my activity details with my care team. This information will assist
my care team in monitoring my activity and prescribing appropriate activity plans,
remotely.
I further understand that if I choose to participate in this program, the FitBit hardware
will be loaned to me on a temporary basis (12 weeks) and must be returned to my care
provider at the end of this timeframe.
I understand that I must create a profile with FitBit at https://www.fitbit.com/en-ca/home,
and will be responsible for reading, accepting, and following the FitBit Terms of Service
and Privacy Policy. These terms include, but are not limited to, FitBit’s license to use,
copy, modify, reproduce, use publicly, etc. any photos, video, text, etc. that I choose to
upload to my profile. The Privacy Policy outlines how FitBit collects, stores and uses
your information. Please note that the Privacy Policy indicates that it uses encryption
with many of its services, however no method of transmitting or storing data is
completely secure. Additionally, FitBit is an international company and information you
add to your profile may be stored in various locations, including those outside of Canada,
which may not have the same privacy standards. I understand and agree that I will
provide my care team with access to my activity log in order to facilitate and prescribe
my activity plan. I have had the opportunity to ask any and all questions I may have and
have had all questions answered to my satisfaction.
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Letter of Information and Consent: Closed Protocol
Study Title:

Virtually Delivered Lifestyle Program Integrating
Wearable Technology and Exercise Prescriptions in
Patients with Type 2 Diabetes (STAND-VAT): A
Feasibility Study

Principal Investigator:

Sonja M. Reichert, MD MSc CCFP. Assistant Professor,
Department of Family Medicine, Western University.

1. Introduction and Invitation to Participate
As you have type 2 diabetes and participated in the one-hour Lifestyle is Medicine
education class you are being invited to participate in our research study.
2. Purpose of the Letter
The purpose of this letter is to provide you with the information that is required for you to
make an informed decision about participating in our study. We invite you to read this
letter closely.
3. Background and Purpose of this Study
The St. Joseph’s Primary Care Diabetes Support Program (PCDSP) has offered an inclinic group program called STAND for people interested in learning more about exercise
and nutrition as one type of treatment for type 2 diabetes for the last few years.
Due to COVID-19 restrictions, the program will now be delivered virtually starting in
September. Virtual care delivery (i.e., video healthcare appointments) is becoming more
common and can decrease travel time and other hassles. Additionally, wearable
technology (e.g., FitBits) are now often used in remote healthcare monitoring. However,
we do not know if it is feasible to incorporate supervised exercise programming and
wearable activity monitors into the clinic’s STAND program.
We will offer you the use of activity monitors (a FitBit). We also hope to understand if
we can coach you virtually to use this wearable technology and if it affects your
confidence in your diabetes management and exercise behaviours. You are being asked to
participate because the information collected from your experiences and responses in this
study will help us decide if virtual delivery of the STAND program is something we can
offer again in the future, and if so, how to improve it.
4. Study Design and Procedures:
If you choose to participate in this study, you will need to first be eligible and medically
cleared by a PCDSP nurse practitioner or doctor before participating in this study. The
total time you will be involved with the study will be a one-week preparation, two-week
baseline, six-week intervention. Please note, the follow up testing and questionnaires will
occur one week after the sixth week intervention.
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During the six-week intervention period, you will be required to attend the program’s
virtual one-hour group classes every two weeks (at a prearranged time). The following is
a description of additional features of the study (on top of the normal diet/exercise
counseling (which includes wearable glucose monitors, FreeStyle Libre sensors (Abbott))
you would usually receive for six weeks through the regular STAND program at the
PCDSP if you chose not to participate in this study).
To begin, the clinic will have already provided you this Letter of Information and four
short surveys to review. A study investigator will video call you to review any questions
you have, then you will confirm your consent to participate via REDCap. REDCap is a
secure, online data collection platform; you will be sent the link via email to access the
consent page. On the same call (if you agree to participate), you will answer the survey
questions.
The day before your first virtual group orientation class, you will drop by the clinic to
pick up your FitBit and FreeStyle Libre. During the virtual orientation class, one of the
researchers and clinic staff will teach you how to set-up and use your FitBit, along with
other parts of the normal STAND program. You will wear the FitBit every day after this
orientation class until the program completes. Two weeks after the orientation class, you
will attend your first virtual STAND-VAT class. At the first class you will receive your
first personalized step count goal. This program will be individually adjusted every two
weeks.
You will be asked to send in your FitBit data and FreeStyle Libre glucose numbers to the
clinic the day before each group class you attend (on Sunday). A PCDSP practitioner will
review your glucose data, and the exercise specialist apart of this study (MH) will review
your FitBit data. This information may be discussed during the one-hour virtual STAND
group session if you volunteer to do so and will be used to create a new bi-weekly
personalized step count goal by the exercise specialist. Within one day of the class, you
will receive a summary email about your new step goal.
For the six weeks of the intervention, one week after each class, you will be briefly
contacted by telephone by the exercise specialist (MH). This call is to discuss how your
exercise is going, confirm your exercising is safe, and if you have any technology or
study questions. During the seventh week of the intervention, you will answer two of the
surveys you completed before the program started and an exit survey. The exit survey
will ask you about your study experience and for any suggestions for improvement. You
will also recomplete the two-minute fitness test. These surveys and fitness test will be
done on a one-on-one video call with the Master’s student and a physician present. After
the first six weeks of the intervention, the telephone calls with the exercise specialist and
glucose monitor supply will end. You will continue to attend classes and wear your
FitBit, send in your FitBit data and receive exercise prescriptions. You will be required to
return your FitBit to the clinic after the six weeks of the intervention ends.
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5. Voluntary Participation:
Your participation in this study is voluntary. You may decide not to be in this study, or to
be in the study now and then change your mind later. You also may choose to skip any
survey questions that you do not wish to answer, by saying, “pass”. You may leave the
study at any time without affecting your care. We will give you any new information that
is learned during the study that might affect your decision to stay in the study.
Additionally, sharing exercise or glucose data with the rest of the class for learning
purposes is completely voluntary. You may refuse to share data with the rest of the class
without any consequence to your care and will be followed up with a Certified Diabetes
Nurse Educator to make sure you understand your own data.
6. Withdrawal from the Study:
If you decide to withdraw from the study, the information that was collected during the
study can be removed upon request. No new information will be collected without your
permission. You reserve the right to delete your FitBit account if you wish. You, solely,
hold your own access to your FitBit account.
7. Benefits:
You may not directly benefit from being in this study. However, you may benefit from
this study in a few ways.
a) You will have the opportunity to self-monitor your current physical activity levels
by using the FitBit.
b) You will receive personalized exercise programming with support from a coach
and other peers to work towards your exercise goals.
Overall, the information learned from this study may be used to lead improved diabetes
management strategies in the future, which can benefit other people with diabetes too.
8. Risks, Harms, or Inconveniences:
Expected risks or discomforts related with participating in this study include disruption of
your personal time to complete the required needs of the study. We do not expect any
severe risks, harms, or inconveniences, however there are a few you need to be aware of:
A) Inconveniences: You will need to send in FitBit data every two weeks. You will also
be contacted every other week (on weeks without classes) by a researcher to discuss
your exercise routine and technology experiences. You may experience technical
difficulties (i.e. struggling to figure out your FitBit or how to send your data in),
which may increase frustration and/or result in requiring more time than you
anticipate. Please note that a clinic IT person or the Master’s Kinesiology student will
be available to assist you if you need help.
B) Privacy: There is always a possibility for privacy breaches. We have taken
precautions using encrypted, password protected files and a research-grade data
storage server. Our video calling platform is secure and uses encryption software.
Like online shopping, teleconferencing/videoconferencing technology has some
privacy and security risks. It is possible that information could be intercepted by
unauthorized people (hacked) or otherwise shared by accident. This risk can’t be
completely eliminated. It is recommended that you use your home computer or

97

personal device, and not a shared or work device to ensure privacy. For your FitBit
account, we will put your email address, birth year, sex, and height/weight in order to
get accurate feedback for us and you. Below, you will be asked to review and sign the
Patient Acknowledgment and Consent Form FitBit® Activity Program.
C) FitBit Data: FitBit data shared with the study investigators will be used using the St.
Joseph’s Health Care (SJHC)’s secure patient file sharing platform. We will also ask
for your email address, as it will be necessary to communicate with you occasionally
using email i.e. to send you study questionnaires and study information. Please be
aware that email is not a secure or confidential form of communication. As the
message leaves SJHC, it is sent across the Internet, where it could be intercepted and
read. For this reason, SJHC cannot guarantee the security of messages that are sent to
and by us. We will not use email to communicate sensitive personal or health
information. Email will NOT be used to communicate emergency or urgent health
matters.
D) Negative feelings: As changing your lifestyle habits can be very hard, especially on
top of daily self-management practices, the study has the potential to:
a. cause feelings of distress or frustration (i.e., stress from learning to use new
technology), or
b. decrease confidence or feelings of disappointment about lifestyle changes (i.e.,
you finding you are not achieving your goals like you wanted). We will work with
you to make your goals achievable. One of the researchers or exercise leader can
always be reached if you are having difficulties with your prescription.
c. Safety: As with any exercise, you may be at risk for mild soreness (if you have
not exercised in a while), developing a foot blister, and even hypoglycemia if you
are taking medication that can cause hypoglycemia. Before starting the program,
you will be medically cleared to ensure high levels of safety while participating in
this study. We will also teach you how to exercise safely as a person with Type 2
Diabetes.
9. Confidentiality:
Special care will be given to protect your confidentiality. Identifying information (phone
number, email address, names, and date of birth), will be kept separate from our main
study data and will be stored on a password protected, secure, research grade platform
(REDCap). All other electronic study documents will be labeled with only your study
number and will be encrypted, and password protected on the Western OneDrive; this
data will be wiped after the study completes. All study-related information will be kept
for 15 years after the study has been completed. Representatives of Western’s Research
Ethics Board and the Lawson Quality Assurance and Education Program may contact you
or may access your study-related records to monitor the conduct of the research.
The information from this research project will be submitted, when the study ends, for
publication in a peer-reviewed academic journal as well as presented at related
conferences. You will not be named in any report, publication or presentation resulting
from this study.
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10. Costs:
You will not have to pay to participate in this study.
11. Rights as a Participant:
You do not waive any legal right by signing this consent form
12. Conflict of Interest:
Some of the clinicians are our study investigators. Thus, the doctor or nurse practitioner
treating you may also be the practitioners in charge of this study. Participating in this
study, however, will in no way jeopardize your care at PCDSP.
13. Questions About the Study:
If you have any questions regarding your participation in the study, please contact one of
our co-investigators, Elizabeth Harvey (RNEC, MScN CNS/ Nurse Practitioner) at or Dr.
Sonja Reichert (Co-Principal Investigator) or Dr. Marc Mitchell (Co-Principal
Investigator), or Madison Hiemstra (Master’s Student at Western University).
If you have any questions about your rights as a research participant or the conduct of this
study, you may contact SJHC Patient Relations Phone.
Patient Acknowledgment and Consent Form: FitBit® Activity Program
As part of my care at the Primary Care Diabetes Support Program, I understand that I
may choose to participate in a fitness program/evaluation whereby I will wear a FitBit
Inspire HR and share my activity details with my care team. This information will assist
my care team in monitoring my activity and prescribing appropriate activity plans,
remotely.
I further understand that if I choose to participate in this program, the FitBit hardware
will be loaned to me on a temporary basis (12 weeks) and must be returned to my care
provider at the end of this timeframe.
I understand that I must create a profile with FitBit at https://www.fitbit.com/en-ca/home,
and will be responsible for reading, accepting and following the FitBit Terms of Service
and Privacy Policy. These terms include, but are not limited to, FitBit’s license to use,
copy, modify, reproduce, use publicly, etc. any photos, video, text, etc. that I choose to
upload to my profile. The Privacy Policy outlines how FitBit collects, stores and uses
your information. Please note that the Privacy Policy indicates that it uses encryption
with many of its services, however no method of transmitting or storing data is
completely secure. Additionally, FitBit is an international company and information you
add to your profile may be stored in various locations, including those outside of Canada,
which may not have the same privacy standards.
I understand and agree that I will provide my care team with access to my activity log in
order to facilitate and prescribe my activity plan.
I have had the opportunity to ask any and all questions I may have and have had all
questions answered to my satisfaction.
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Appendix E
Group education class topics identified by the Behaviour Change Techniques Taxonomy (BCT)
(Michie et al., 2013)
BCT
BCT
Intervention Component
Number
1.2
Problem solving Encouraged identifying barriers from previous experiences (and other
behaviour changes) and the value of anticipating barriers prior to them
occurring.
1.4
Action planning Discussed the importance of action planning and how to do it.
2.4
Self-monitoring Discussed the importance of self-monitoring behaviours and methods on
of behaviour
how (and provided some tools as well) to track their activity.
3.2
Social support
Discussed a) the benefit of social support when it comes to behaviour
(practical)
change b) how to identify those who support/don’t support the person, and
c) how to ask for support.
4.1
Instruction on
Repetitive discussion on the how to achieve minutes of exercise and daily
how to perform
step count goals. Discussed how to start out and progress exercise, and
a behaviour
how to individualize exercise habits to optimize exercise behaviour
adoption and maintenance.
4.2
Information of
Encouraged participants to become mindful of (a) certain triggers that
Antecedents
result in habitual behaviours (and how to use the trigger while changing
the habit sequence) and (b) mindful or recording about thoughts, self-talk
before initiating behaviour performance (to understand what makes them
successful in doing a healthy exercise or food behaviour).
5.4
Monitoring
Discussed being mindful and/or recording feelings after performing a
emotional
behaviour (journal, phone notes, smiley faces on the calendar). E.g.,
consequences
monitoring their overall feeling (e.g., glad they did it). If negatively
viewed, reflecting on the why. Encouraged awareness of the emotional
aftereffects of exercise, so that they can use the memory of positive
experiences to motivate them to engage in the behaviour again.
5.6
Information
Discussed the mental health benefits of exercise and health food.
about emotional
consequences
7.1
Prompts/cues
Discussed how to set up cue/triggers to initiate habitual sequences.
7.2
Cue signaling
Discussed the importance of choosing a reward that will make you want to
reward
develop a habit; how to make a reward the end point of a habit cycle.
8.2
Habit
E.g., discussed replacing sedentary time with light physical activity or
substitution
exercise strategies, or replacement of types of foods with low carbohydrate
alternatives.
8.3
Habit formation Discussed how rehearsal and repetition of behaviour leads to habit
formation.
10.4
Social reward
Congratulated all participants on an achievement, regardless of
achievement size. E.g., “Everyone’s glucose levels are looking amazing!
Tina, I see improvements in those morning spikes! Way to go!”
11.2
Reduce negative Advised ways to reduce negative emotions to help facilitate behaviours.
emotions
Discussions focused on recognizing and addressing negative thoughts in
relation to behaviour change.
13.1
Identification of Encouraged the class to share as many experiences and thoughts with
self as a role
others and the importance as to why sharing is important (as related
model
experiences may motivate or set an example for others to try new healthy
behaviours/strategies).
15.3
Focus on past
Instructed participants to think about what has made them successful
success
previously with exercising or eating healthy (or any behaviour change).
15.4
Self-talk
Instructed participants to talk back to their negative thoughts and to talk to
positively to themselves. E.g., “I will feel refreshed after this walk.”

101

Appendix F
Exercise Prescription: Aerobic Exercise
Participants received individualized aerobic exercise prescriptions created by the exercise
specialist (with medical clearance from the investigating physician). New step count
prescriptions were given bi-weekly via an official email stating their new daily step count
goal. Additionally, the email contained positive feedback about the past-two weeks
performance (e.g., “You got 9/14 days of your step goal, which is amazing! This week,
with your new step count goal, think of an activity goal that can help you try to
consistently achieve this step count each day”). If the goal achievement was low, other
positive feedback was given.
This was a feasibility study that looked at remotely offering individualized exercise
prescriptions utilizing a wearable activity monitor and did not test the efficacy of a step
count prescription. Aerobic exercise was chosen for this study to increase safety, as
opposed to resistance training, which is often new to many people and may require
intensive guidance from an exercise specialist (Sigal et al., 2018).
An adaptive goal setting approach was utilized, as it has shown to be appropriate for
increasing and/or creating manageable goals for participants (Adams et al., 2013). This
approach was taken so that the step goals did not continue to rise if the participant was
not similarly ramping up their step count (unlike other “static” interventions that do not
consider variability in daily life contexts/events and within person variability that affect
daily step counts and activity) (Bickel and Vuchinich, 2000; Adams et al., 2013). The
Look AHEAD trial prescribed a reasonable 250-step goal increase each week over the
course of the study, though the prescription was linearly static (increased regardless).
This adaptive approach allowed individualized daily step count targets to be calculated
using activity data from the previous two weeks.
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Appendix G
Description of Protocol
Virtual Technology Orientation Preparation (only for ‘closed’ protocol)
The morning prior to the virtual technology orientation class, participants drove by the
diabetes clinic to pick-up study supplies (FitBit Inspire 2™ device, four FreeStyle®
Libres, and the study booklet) via curbside pick-up.
Technology Orientation Class (in person for ‘open’ protocol, on WebEx® for ‘closed’
protocol)
The technology orientation class helped orient and teach participants how to set up and
use the program technology. First, a CDNE taught participants how to apply FreeStyle®
Libre (for future applications) and understand the basics of data interpretation.
Participants downloaded, created accounts for, and learned how to use the FitBit®
smartphone app and FreeStyle® Libre’s associated app, LibreLink. Participants linked
their LibreLink account to the clinic’s LibreView account. Participants were encouraged
to keep push-notifications on for reminders to move every hour on their FitBit Inspire
2™. Procedures for downloading and exporting FitBit Inspire 2™ data and other study
tasks were discussed. Participants were given instructions about their FitBit Inspire 2™,
exercising safely, and participant study tasks via a pre-printed study booklet. As well, an
email containing links to investigator-created video tutorials and other helpful videos
posted on YouTube, was sent after class. Participants wore the FitBit Inspire 2™ and
FreeStyle® Libre immediately thereafter and continued to wear it the rest of the virtual
lifestyle medicine program. Participants received study supplies in-person at this class for
OPEN protocol.
T2: Baseline Step Count and Familiarization
Participants wore their FitBit Inspire 2™ and FreeStyle® Libre’s for two weeks, prior to
the first group education class. This served as a baseline to collect step (informing their
individualized step count prescription) and glucose data and to familiarize participants
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with the technology. Participants were encouraged to try to remain in pre-study activity
levels and behaviour. One week after the technology orientation class, the exercise
specialist briefly called participants to encourage: timely glucose scanning, exploration of
the LibreLink and FitBit® apps, and FitBit Inspire 2™ features, and clarify on study
procedures.
Intervention (Weeks 1 to 6)
During the six-week intervention, participants continued to receive normal or standard
clinical care at the diabetes clinic as determined by their clinical team, in addition to the
intervention. Participants attended group education classes and received a new exercise
prescription on week 1, 3 and 5. One-on-one check-in calls were completed on week 2, 4
and 6.
Follow-Up
Participants completed the Stanford Self-Efficacy survey, PAID-5, and exit survey.
Participants returned their FitBit Inspire 2™ devices to the clinic.
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Appendix I
Socio-demographics Survey
1. What do you consider to be your racial/ethnic background? Please check  one
(1) of the following boxes:
1. Aboriginal (includes Inuit, Métis peoples of Canada, First Nations)
2. Arab (includes Egyptian, Kuwait, Libyan)
3. West Asian (includes Afghan, Assyrian and Iranian)
4. Chinese
5. Filipino
6. Japanese
7. Korean
8. South Asian (includes Bangladeshi, Punjabi, Sri Lankan)
9. Black (includes African, Nigerian, Somali)
10. Latin American (includes Chilean, Costa Rican, Mexican)
11. South East Asian (includes Vietnamese, Cambodian, Malaysian, Laotian)
12. White (Caucasian)
13. Other (specify):
14. Multiple cultural backgrounds (specify):
2. What is your marital/relationship status? Please check  one (1) of the following
boxes:
 Single
 Married or equivalent (i.e. common law; same sex)
 Separated or equivalent
 Divorced
 Widowed
3. Which option best matches your current work status? Please check  one (1) of
the following boxes:
 Employed full-time, that is, 35 more hours per week
 Employed part-time, that is, less than 35 hours per week
 Unemployed, but looking for work
 Student
 Retired
 Not in the paid workforce (homemaker, unemployed but not able to work e.g., due
to disability, chronic illness, etc.)
4. What is the highest level of education you have completed? Please check  one (1)
of the following boxes:
 Less than high school (no certificates, diplomas or degrees)
 High school graduation certificate
 Trades certificate
 College certificate or diploma: a certificate from a community college, CEGEP,
school of nursing, theological college or private college
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 University: a certificate below the bachelor level, bachelor’s degree, certificate
above the bachelor level, master’s degree, earned doctorate or a professional
degree in medicine, dentistry, veterinary medicine, or optometry.
5. What is your best estimate of the total income received by all household members,
from all sources, before taxes and deductions, last year? For example, if there are two
(2) people living in your house, each making $30,000 per year ($60,000 total), you would
select $35,001 to $65,000 below. Please check  one (1) of the following boxes:
 Less than $25,000
 $25,001 to 50,000
 $50,001 to 75,000
 $75,001 to $100,000
 Greater than 100,000
6. Do you own a car? Please check  one (1) of the following boxes:
 Yes, I own a car.
 No, but I have frequent access to borrowing a car.
 I do not own a car.
7. What is your main method of transportation? Please check  one (1) of the
following boxes:
 Vehicle
 Bike
 Bus
 Taxi
 Walk
 Scooter/Motorcycle
8. In the past 3 months, have you been active for a minimum of 30 minutes/day on at
least 3 days of the week? Please check  one (1) of the following boxes:
 Yes
 No
9. In the past 6 months, have you been smoking or quit smoking? As well, are you
frequently exposed to environmental tobacco smoke? Please check  the following
boxes appropriate to your situation:
 Yes, I have been smoking or have recently quit smoking.
 No, I have not smoked or recently quit smoking in the past 6 months.
 I am exposed to frequent environmental tobacco smoke.
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Appendix K
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Appendix L
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Appendix M
Instruments Used
PCDSP Modified Physical Activity Report Questionnaire (PAR-Q)
The PAR-Q (Freehan et al., 2018) is a nine-item questionnaire that is used to assess a
patient’s medical safety clearance to exercise. It has been modified by, and is used as a
part of, the in-person lifestyle medicine program at the diabetes clinic.
Stanford Self-Efficacy Scale
The Stanford Self-Efficacy Scale is a reliable, validated six-item questionnaire that
assesses the self-efficacy to manage a chronic disease, including exercise (Lorig et al.,
2001; Ritter & Lorig, 2014). Each question is ranked from 1 (not confident) to 10 (very
confident). The final score is the mean of the scores, where higher scores mean higher
self-efficacy (range 1 to 10).
Five-Item Problem Areas in Diabetes (PAID-5) Scale
The five-item Problem Areas in Diabetes Scale (PAID-5) is a valid and reliable short
version of the PAID Scale, focusing on emotional distress related to diabetes (McGuire et
al., 2010). Each question is ranked from zero (not a problem) to four (serious problem).
The range is between 0 and 20. A total score of eight or greater indicates possible
emotional distress and may warrant further investigation.
Technology Survey
This is a non-validated, descriptive tool that assesses current level of use of technologies
(i.e., desktops, smartphones phones, wearable devices) and the personal functional use of
the technologies. It also assesses a person’s comfort and self-efficacy with using
technologies related to the study. This survey was created by the diabetes clinic’s staff
input and investigators to describe participant’s baseline characteristics.
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Exit Survey
The exit survey collected data on participants’ perceived levels: of program satisfaction,
level of technology difficulties, privacy protection, and help for increasing physical
activity. It also inquired about relationship of learning and motivation with the
FreeStyle® Libre, FitBit Inspire 2™, and other aspects of the program. It covers the
study’s acceptability outcomes. The exit survey was informed by the study’s primary
feasibility outcomes and by a similar pilot study’s focus group responses (Jiwani et al.,
2020).
FitBit Inspire 2™
The FitBit Inspire 2™ is a wearable activity monitor containing a 3-axis accelerometer,
optical heart rate monitor, and vibration motor. It was used to track step counts and
minutes of sedentary behaviour. The device dimensions are 37 by 16 mm. The device is
water resistant to 50 meters and has a battery life up to 10 days. It can store 7 days of
detailed (minute by minute) motion data and saves daily totals for the past 30 days. It has
a syncing range of 30 feet. The wearable activity monitor data is synced to the FitBit®
app.
FitBit® Smartphone Application
The FitBit® app software (version 3.0+) was downloaded onto participants’ phones
(Android or iPhone) in order to upload and save physical activity data. The platform can
also be accessed on a computer (if desired). The FitBit Inspire 2™ is automatically and
wirelessly synced to computers and 200+ leading iOS and Android devices using
Bluetooth LE wireless technology (FitBit Inc., 2020). To upload/sync data from the
FitBit® app onto the main server, Internet connection is required. The app retrieves data
from the FitBit Inspire 2™ and stores it on the participant’s user account (investigators
did not have access to any account data). The FitBit® app and FitBit Inspire 2™ display
hourly goals of 250 steps or more and was set to read for a 12-hour range (the time range
is customizable (e.g., 8:00am to 5:00pm)).
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FitBit® Desktop Platform
Participants were asked to sync their FitBit® app to the Internet in order to make their
step count data available on their FitBit® desktop platform. The platform is available on
https://www.fitbit.com, where participants had to select “My Dashboard” to view their
data. The diabetes clinic could not extract any data off the FitBit® site, rather the
participant downloaded their own data. On the settings page, the data export option is
available. Participants selected the time frame of a custom range of two dates to ensure
the proper time frame two weeks were exported to a Microsoft Excel file. Participants
uploaded this information to the secure file transfer website, https://filesafe.lhsc.on.ca.
WebEx®
WebEx® is a secure video conferencing and online meeting software that features endto-end encryption. WebEx® offers specific healthcare platform options, such as highquality video and audio for face-to-face consultations between patients and practitioners.
Participants could join calls from a link sent from the diabetes clinic’s encrypted email.
Participants could join from their desktop or smartphone WebEx® app.
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Appendix N
Baseline Physiological Date (extracted from PCDSP EMR by Dr. Reichert)
1. Sex
❑ Male
❑ Female
2. Age : __________ years
3. Height (cm) : ___________
4. Weight (kg): _______
5. Years since diagnosis : _________ years
6. Comorbidities (Select all that apply)
❑ Cardiovascular
❑ Psychatric
❑ Peripheral Vascular
❑ Renal
❑ Visual
7. List of Cardiovascular Comorbidities :
❑ CAD
❑ Heart Failure
❑ Angina
❑ Atrial Fibrillation
❑ Arrhythmia
❑ CVD
❑ CABG
❑ HTN
❑ PVD
❑ Other: ____________
8. List of Psychiatric Comorbidities :
❑ Depression
❑ Diabetes Depression
❑ Anxiety
❑ Bipolar
❑ MDD
❑ Misc.
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9. List of Renal Disease
❑ Chronic Kidney Disease
o Stage 1 (eGFR 90+)
o Stage 2 (eGFT 60-89+)
o Stage 3 (eGFR 30-59)
o Stage 4 (eGFR 15-29)
❑ Other : ________________
10. List of Visual diseases :
❑ Cataracts
❑ Retinopathy
❑ Other
11. Blood Pressure (SBP/DBP) : ___________
12. Last A1C measurement (%) : ____________
______________
13. Last weight (kg) : ________
14. Last measured height (cm) :
15. Diabetes Medication
❑ Insulin
o Type of Insulin :
❑ Short Acting
❑ Long Acting
o Insulin Dose (units per day) : ___________
❑ DD4
o DD4 Type : __________
❑ GLP
o GLP Type : ___________
❑ Metformin :
o Metformin Type : ___________
❑ Sulfonlyurea
o Sulfonlyurea Type : __________
❑ SGLT2
o SGLT2 Type : ___________
❑ TZD
o TZD Type : ______________
❑ Alpha glucosidase inhibitor
o AGI Type : ____________

Lab Records Date :
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Appendix P
Technology Survey Results
Do you use a…

Yes

No

Cellphone/Smartphone
Tablet?

100%
70%

30%

Desktop
40% (4)

Do you primarily use
a laptop or desktop?

None
10% (1)

How frequently do
you use these
technologies?

At least one time per
week

One time per day

2 or more times per day

Cellphone/Smartphone

-

10% (1)

90% (9)

Tablet

14.3% (1)

28.6% (2)

57.1% (4)

Desktop

-

67% (2)

33% (1)

Laptop

40% (2)

20% (1)

40% (2)

How is your ___
connected to the
internet?
Cellphone/Smartphone
Tablet
Computer/Desktop

Unlimited
WiFi (wireless)
100% (10)
100% (7)
100% (9)

Do you use wearable
technology?

What kind of
wearable
technology?

What can you do
with your
wearable
technology?

.

Laptop
50% (5)

Limited
WiFi
(wireless)
-

Unlimited Mobile
data (i.e.,
megabytes)
20% (2)
-

Limited Mobile
data (i.e.,
megabytes)
20% (2)
-

Yes

No

40% (4)

60% (6)

Wearable glucose
monitor

Activity Tracker
(e.g., basic FitBit)

Smartwatch (e.g., Apple
or Samsung Watch)

50% (2)

50% (2)

50% (2)

Flash
glucose
monitoring

Step
Counting

Sedentary behaviour
reminders

Heart Rate

Other

25% (1)

100% (4)

100% (4)

75% (3)

-
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Technology Survey Results continued…
Technology Self-Efficacy
I am very confident in my abilities to
use digital technology
I often have difficulty when trying to
learn how to use a new software
package, or online application
I always seem to have problems when
trying to use digital technology
I find having a person showing me
works best when I am learning how to
do something new
I find working through it myself
works best when I am learning
something new
I need to have someone to call for
help if I get stuck

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

-

-

10% (1)

50% (5)

40% (4)

20% (2)

20% (2)

20% (2)

30% (3)

10% (1)

20% (2)

30% (3)

40% (4)

10% (1)

-

-

-

10% (1)

30% (3)

60% (6)

-

20% (2)

20% (2)

30% (3)

30% (3)

10% (1)

10% (1)

20% (2)

30% (3)

30% (3)

Access the
internet

Video Chat
(e.g., Skype,
Zoom,
Facebook
messenger)

Social media
(e.g.,
Facebook,
Twitter etc.)

e-mail

100% (10)

100% (10)

100 % (10)

90% (9)

100 (10%)

60% (6)

Tablet (n=6)

100% (6)

100% (6)

83% (5)

100% (6)

100% (6)

83% (5)

Computer/Desktop
(n=9)

44.4 (4)

100% (9)

66.7% (6)

77.8% (7)

100% (9)

44.4% (4)

Which of the
following can you
do with these
technologies?

Take
Pictures

Smartphone (n=10)

other
apps
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Appendix Q
Other Descriptive Exit Survey Responses
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Appendix R
Exit Survey Written Responses
Participants’ brief responses providing feedback on program experience collected from
exit survey (displayed in direct quotes).
Items liked about the program
• The group input and information on diet and exercise
• Ability to understand more about diabetes.
• Learning about carbohydrates really helped
• Guidance on what to eat and how to exercise
• Libre helped me to see what happens to my glucose level at different situations
• I was able to see my movement level with Fitbit throughout the day.
• One on one answers.
• Updated information.
• Liked the Libre and the step prescription.
• Contact with clinic.
• Keeping track.
• Reading my glucose and seeing out reacts to my outcomes.
Things disliked/ (room for improvement) in the program
•
•
•
•
•
•
•
•
•

More time to be in the program.
Advance notice of curriculum to be spoken about, just to make it clearer and
help in conversation.
Print out of class material in advance; maybe homework to prepare for class.
The FitBit screen was too small, could not read when outside in bright light.
During the group session, it would be helpful if the facilitators can mute and
unmute participants.
Exercise challenges.
Eating food together to see what is good/not good to eat (visual learners); to all
check out the Libre’s together as a group.
Privacy issues. Felt uncomfortable about practitioners commenting on other
people’s medication and how they are doing with their glucose patterns.
Small exercise videos to watch and try.
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Appendix S
Bi-weekly group glycemic variable means.
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